Petition for Writ of Certiorari — Joseph R. Biden, Jr., President of the United States, et al., Petitioners v. Feds for Medical Freedom, et al.
Supreme Court briefJul 21, 2023
Ask Donna
What actually matters in this document.
Text
No.
In the Supreme Court of the United States
JOSEPH R. BIDEN, JR., PRESIDENT OF THE UNITED
STATES, ET AL., PETITIONERS
v.
FEDS FOR MEDICAL FREEDOM, ET AL.
ON PETITION FOR A WRIT OF CERTIORARI
TO THE UNITED STATES COURT OF APPEALS
FOR THE FIFTH CIRCUIT
PETITION FOR A WRIT OF CERTIORARI
ELIZABETH B. PRELOGAR
Solicitor General
Counsel of Record
BRIAN M. BOYNTON
Principal Deputy Assistant
Attorney General
BRIAN H. FLETCHER
Deputy Solicitor General
MATTHEW GUARNIERI
Assistant to the Solicitor
General
CHARLES W. SCARBOROUGH
SARAH CARROLL
CASEN B. ROSS
DANIEL WINIK
Attorneys
Department of Justice
Washington, D.C. 20530-0001
SupremeCtBriefs@usdoj.gov
(202) 514-2217
QUESTION PRESENTED
In 2021, the President issued an executive order requiring employees of the Executive Branch to be vaccinated against COVID-19 as a condition of their employment, subject to religious and medical exemptions.
In the decision below, the en banc Fifth Circuit held
that respondents could challenge that requirement in
district court notwithstanding the provisions of the Civil
Service Reform Act of 1978, Pub. L. No. 95-454, 92 Stat.
1111, channeling federal employees’ challenges to adverse personnel actions to the Merit Systems Protection Board, subject to review by the Federal Circuit.
The Fifth Circuit also affirmed a preliminary injunction
forbidding the government from enforcing the vaccination requirement against any federal employee nationwide. Roughly six weeks after the Fifth Circuit issued
its decision, the President revoked the executive order
at issue in this case as part of a broader wind-down of
COVID-19 emergency policies based on changed publichealth conditions. The question presented is as follows:
Whether, pursuant to United States v. Munsingwear,
Inc., 340 U.S. 36 (1950), this Court should vacate the
court of appeals’ judgment and remand with instructions to direct the district court to vacate its order
granting a preliminary injunction as moot.
(I)
PARTIES TO THE PROCEEDING
Petitioners (defendants-appellants below) are Joseph R. Biden, Jr., in his official capacity as President
of the United States; Antony Blinken, in his official capacity as Secretary of State; Janet Yellen, in her official
capacity as Secretary of the Treasury; Lloyd J. Austin
III, in his official capacity as Secretary of Defense; Merrick B. Garland, in his official capacity as Attorney General; Debra A. Haaland, in her official capacity as Secretary of the Interior; Tom Vilsack, in his official capacity as Secretary of Agriculture; Gina M. Raimondo, in
her official capacity as Secretary of Commerce; Julie A.
Su, in her official capacity as Acting Secretary of Labor;
Marcia Fudge, in her official capacity as Secretary of
Housing and Urban Development; Pete Buttigieg, in his
official capacity as Secretary of Transportation; Jennifer M. Granholm, in her official capacity as Secretary
of Energy; Denis McDonough, in his official capacity as
Secretary of Veterans Affairs; Alejandro N. Mayorkas,
in his official capacity as Secretary of Homeland Security; William J. Burns, in his official capacity as Director of the Central Intelligence Agency; Bill Nelson, in
his official capacity as Administrator of the National
Aeronautics and Space Administration; Kilolo Kijakazi,
in her official capacity as Acting Commissioner of Social
Security; Samantha Power, in her official capacity as
Administrator of the United States Agency for International Development; Shalanda D. Young, in her official
capacity as Director of the Office of Management and
Budget; Avril Haines, in her official capacity as Director of National Intelligence; Daniel Hokanson, in his official capacity as Chief of the National Guard Bureau;
Robin Carnahan, in her official capacities as Administrator of the General Services Administration and CoChair of the Safer Federal Workforce Task Force;
(II)
III
Kiran Ahuja, in her official capacities as Director of the
Office of Personnel Management and Co-Chair of the
Safer Federal Workforce Task Force; Lesley A. Field,
in her official capacity as a member of the Federal Acquisition Regulatory Council; Matthew C. Blum, in his
official capacity as a member of the Federal Acquisition
Regulatory Council; Jeffrey A. Koses, in his official capacity as a member of the Federal Acquisition Regulatory Council; John M. Tenaglia, in his official capacity
as a member of the Federal Acquisition Regulatory
Council; Karla S. Jackson, in her official capacity as a
member of the Federal Acquisition Regulatory Council;
the United States of America; the United States
Department of State; the United States Department of
the Treasury; the United States Department of Defense; the United States Department of Justice; the
United States Department of the Interior; the United
States Department of Agriculture; the United States
Department of Commerce; the United States Department of Labor; the United States Department of Housing and Urban Development; the United States Department of Transportation; the United States Department
of Energy; the United States Department of Veterans
Affairs; the United States Department of Homeland Security; the Central Intelligence Agency; the National
Aeronautics and Space Administration; the Social Security Administration; the United States Agency for International Development; the General Services Administration; the Office of the Director of National Intelligence; the Office of Personnel Management; the Office
of Management and Budget; the National Guard Bureau; the Safer Federal Workforce Task Force; and the
IV
Federal Acquisition Regulatory Council.* Jeffrey
Zients was named as a defendant below in his official
capacity as Co-Chair of the Safer Federal Workforce
Task Force; during the pendency of the litigation,
Zients vacated that office and was succeeded by Ashish
Jha, who has also now vacated the position.
Respondents (plaintiffs-appellees below) are Feds
for Medical Freedom; Local 918, American Federation
of Government Employees; Highland Engineering,
Inc.; Raymond A. Beebe, Jr.; John Armbrust; N. Anne
Atkinson; Julia Badger; Michael Ball; Craigan Biggs;
Laura Brunstetter; Mark Canales; Michele Caramenico; Andrew Chamberland; David Clark; Diane
Countryman; Kevin Dantuma; Jose Delgado; Jordan
DeManss; George Demetriou; Keri Divilbiss; Mercer
Dunn IV; William Filkins; Jonathan Gragg; Bryon
Green; Thomas David Green; Erika Herbert; Peter
Hennemann; Neil Horn; Carey Hunter-Andrews; Tana
Johnston; Tyler Klosterman; Deborah Lawson; Danie
Lewis; Melissa Magill; Kendra Ann Marceau; Dalia Matos; Stephen May; Steven McComis; Christopher Miller; Joshua Moore; Brent Moores; Jesse Neugebauer;
Joshua Nicely; Leslie Carl Petersen; Patti Rivera;
Joshua Roberts; Ashley Rodman; M. LeeAnne RuckerReed; Trevor Rutledge; Nevada Ryan; James Charles
Sams III; Michael Schaecher; Christina Schaff; Kurtis
Simpson; Barrett Smith; Jace ReNee Smith; Jarod
Smith; Jana Spruce; John Tordai; Sandor Vigh; Christina Vrtaric; Pamela Weichel; David Wentz; Jason
Wilkerson; Patrick Wright; and Patrick Mendoza York.
* Acting Secretary Su is substituted for her predecessor in office,
Marty Walsh, pursuant to Rule 35.3 of the Rules of this Court.
V
RELATED PROCEEDINGS
United States District Court (S.D. Tex.):
Feds for Medical Freedom v. Biden, No. 21-cv-356
(Jan. 21, 2022)
United States Court of Appeals (5th Cir.):
Feds for Medical Freedom v. Biden, No. 22-40043
(Mar. 23, 2023)
TABLE OF CONTENTS
Page
Opinions below .............................................................................. 1
Jurisdiction .................................................................................... 1
Statutory provisions involved ...................................................... 2
Statement:
A. Civil service background ................................................. 2
B. Executive Order 14,043 ................................................... 5
C. The present controversy ................................................. 7
D. Subsequent developments ............................................ 10
Reasons for granting the petition ............................................. 12
A. This appeal is moot ........................................................ 13
B. The decision below would have warranted review ..... 16
C. Vacatur is appropriate under Munsingwear .............. 25
Conclusion ................................................................................... 29
Appendix A — Court of appeals en banc opinion
(Mar. 23, 2023) ............................................. 1a
Appendix B — Court of appeals panel opinion
(Apr. 7, 2022) ............................................ 103a
Appendix C — Court of appeals stay motion opinion
(Feb. 9, 2022)............................................ 124a
Appendix D — District court order denying stay
(Feb. 11, 2022).......................................... 138a
Appendix E — District court memorandum opinion and
order (Jan. 21, 2022) ................................ 140a
Appendix F — Court of appeals order granting en banc
rehearing (June 27, 2022) ....................... 158a
Appendix G — Statutory provisions:
5 U.S.C. 3301 ............................................ 160a
5 U.S.C. 3302 ............................................ 160a
5 U.S.C. 7301 ............................................ 161a
(VII)
VIII
TABLE OF AUTHORITIES
Cases:
Page
Already, LLC v. Nike, Inc., 568 U.S. 85 (2013) ...... 13, 14, 16
Alvarez v. Smith, 558 U.S. 87 (2009) ................................... 27
American Fed’n of Gov’t Emps. Local 2018 v. Biden,
598 F. Supp. 3d 241 (E.D. Pa. 2022) .................................. 19
American Fed’n of Gov’t Emps. Local 2586 v. Biden,
616 F. Supp. 3d 1275 (W.D. Okla. 2022) ........................... 18
Arizona v. Mayorkas, 143 S. Ct. 1312 (2023) ..................... 15
Arizonans for Official English v. Arizona,
520 U.S. 43 (1997) ............................................................... 13
Azar v. Garza, 138 S. Ct. 1790 (2018) .................................. 26
Brass v. Biden, No. 21-cv-2778, 2022 WL 11732833
(D. Colo. Oct. 20, 2022) ....................................................... 18
Camreta v. Greene, 563 U.S. 692 (2011) .............................. 16
City News & Novelty, Inc. v. City of Waukesha,
531 U.S. 278 (2001).............................................................. 14
DHS v. New York, 140 S. Ct. 599 (2020) ............................. 25
Donovan v. Vance, 70 F.4th 1167 (9th Cir. 2023) ............... 15
Elgin v. Department of the Treasury,
567 U.S. 1 (2012) ............................................ 4, 10, 18, 20-22
Fornaro v. James, 416 F.3d 63 (D.C. Cir. 2005)................. 21
Free Enter. Fund v. Public Co. Accounting
Oversight Bd., 561 U.S. 477 (2010) ...................................... 2
Health Freedom Def. Fund v. President of the
United States, No. 22-11287, 2023 WL 4115990
(11th Cir. June 22, 2023) .................................................... 16
Hollis v. Biden, No. 21-60910, 2023 WL 3593251
(5th Cir. May 18, 2023) ....................................................... 16
Livingston Educ. Serv. Agency v. Becerra,
No. 22-1257, 2023 WL 4249469
(6th Cir. June 29, 2023) ...................................................... 15
IX
Cases—Continued:
Page
Mayorkas v. Innovation Law Lab,
141 S. Ct. 2842 (2021) ................................................... 12, 28
Missouri v. Biden, No. 22-1104, 2023 WL 3862561
(8th Cir. June 7, 2023) ........................................................ 16
NFIB v. OSHA, 142 S. Ct. 661 (2022) ........................... 23, 24
Payne v. Biden:
602 F. Supp. 3d 147 (D.D.C. 2022), aff ’d,
62 F.4th 598 (D.C. Cir. 2023), petition for cert.
pending, No. 22-1225 (filed June 16, 2023) .............. 22
62 F.4th 598 (D.C. Cir. 2023), petition for
cert. pending, No. 22-1225
(filed June 16, 2023) ....................................... 12, 17, 18
Rydie v. Biden, No. 21-2359, 2022 WL 1153249
(4th Cir. Apr. 19, 2022) ....................................................... 18
Seila Law LLC v. CFPB, 140 S. Ct. 2183 (2020) .................. 2
Trump v. Hawaii, 138 S. Ct. 2392 (2018) ............................ 25
Trump v. International Refugee Assistance,
138 S. Ct. 353 (2017) ........................................................... 28
U.S. Bancorp Mortg. Co. v. Bonner Mall P’ship,
513 U.S. 18 (1994) ......................................................... 26, 27
United States v. Fausto, 484 U.S. 439 (1988) ........... 4, 10, 20
United States v. Microsoft Corp.,
138 S. Ct. 1186 (2018) ......................................................... 27
United States v. Munsingwear, Inc.,
340 U.S. 36 (1950) ........................................12, 15, 16, 26, 29
United States v. Sanchez-Gomez,
138 S. Ct. 1532 (2018) ......................................................... 13
United States v. Texas, 143 S. Ct. 1964 (2023) ................... 25
Yellen v. United States House of Representatives,
142 S. Ct. 332 (2021) ........................................................... 28
X
Constitution, statutes, regulations, and rules:
U.S. Const.:
Art. II ................................................................................. 9
§ 1, Cl. 1 ........................................................................ 2
§ 3 ................................................................................. 2
Art. III .................................................................. 13, 14, 25
§ 2, Cl. 1 ...................................................................... 13
Act of Mar. 3, 1871, ch. 114, § 9, 16 Stat. 514-515 ................. 3
Act of Apr. 10, 2023, Pub. L. No. 118-3, 137 Stat. 6 ........... 11
Civil Service Reform Act of 1978,
Pub. L. No. 95-454, 92 Stat. 1111 ........................................ 3
5 U.S.C. 3132(a)(2)............................................................. 3
5 U.S.C. 7511-7515........................................................... 18
5 U.S.C. 7512 ...................................................................... 4
5 U.S.C. 7513(a) ................................................................. 3
5 U.S.C. 7513(d) ................................................................. 4
5 U.S.C. 7543(a) ................................................................. 3
5 U.S.C. 7701(a)(1)-(2) ....................................................... 4
5 U.S.C. 7703(b) ................................................................. 4
5 U.S.C. 2102(a)(1) ................................................................... 3
5 U.S.C. 2103(a) ....................................................................... 3
5 U.S.C. 3301 .......................................................5, 22, 24, 160a
5 U.S.C. 3301(1) ....................................................... 2, 24, 160a
5 U.S.C. 3301(2) ....................................................... 2, 24, 160a
5 U.S.C. 3302 ........................................................ 2, 5, 22, 160a
5 U.S.C. 3302(1) ............................................................. 3, 160a
5 U.S.C. 3328 .......................................................................... 21
5 U.S.C. 7301 ................................................... 3, 5, 22-24, 161a
28 U.S.C. 1295(a)(9) ................................................................. 4
41 U.S.C. 3301 ........................................................................ 24
Exec. Order No. 12,564, § 1(b), 3 C.F.R. 225
(1986 Comp.).......................................................................... 3
XI
Statutes, regulations, and rules—Continued:
Page
Exec. Order No. 12,674, 3 C.F.R. 215 (1990 Comp.) ............ 3
Exec. Order No. 13,991, § 4, 86 Fed. Reg. 7045, 7046
(Jan. 25, 2021) ........................................................................ 6
Exec. Order No. 14,043, 86 Fed. Reg. 50,989
(Sept. 14, 2021):
Pmbl., 86 Fed. Reg. 50,989 ............................................. 24
§ 1, 86 Fed. Reg. 50,989 .................................................... 5
§ 2, 86 Fed. Reg. 50,990 ................................................ 5, 6
Exec. Order No. 14,099, 88 Fed. Reg. 30,891
(May 15, 2023):
§ 1, 88 Fed. Reg. 30,891 ...................................... 11, 15, 16
§ 2, 88 Fed. Reg. 30,891 .................................................. 11
§ 3, 88 Fed. Reg. 30,891 .................................................. 11
Fed. R. App. P. 41(b) ............................................................... 8
Sup. Ct. R. 10(a) ..................................................................... 19
Miscellaneous:
CDC, COVID Data Tracker, go.usa.gov/xeFyx ................... 5
88 Fed. Reg. 9385 (Feb. 14, 2023) ........................................ 11
Pandemic Response Accountability Comm.,
Top Challenges Facing Federal Agencies:
COVID-19 Emergency Relief and Response Efforts
(June 2020) ............................................................................ 6
Stephen M. Shapiro et al., Supreme Court Practice
(11th ed. 2019) ..................................................................... 17
The White House, White House Report: Vaccination
Requirements Are Helping Vaccinate More People, Protect Americans from COVID-19, and
Strengthen the Economy (Oct. 7, 2021) .............................. 6
In the Supreme Court of the United States
No.
JOSEPH R. BIDEN, JR., PRESIDENT OF THE UNITED
STATES, ET AL., PETITIONERS
v.
FEDS FOR MEDICAL FREEDOM, ET AL.
ON PETITION FOR A WRIT OF CERTIORARI
TO THE UNITED STATES COURT OF APPEALS
FOR THE FIFTH CIRCUIT
PETITION FOR A WRIT OF CERTIORARI
The Solicitor General, on behalf of Joseph R. Biden,
Jr., President of the United States, et al., respectfully
petitions for a writ of certiorari to review the judgment
of the United States Court of Appeals for the Fifth Circuit in this case.
OPINIONS BELOW
The opinion of the en banc court of appeals (App., infra, 1a-102a) is reported at 63 F.4th 366. An earlier
panel opinion (App., infra, 103a-123a) is reported at 30
F.4th 503. The court of appeals’ order regarding a stay
pending appeal (App., infra, 124a-137a) is unreported.
The opinion of the district court (App., infra, 140a-157a)
is reported at 581 F. Supp. 3d 826.
JURISDICTION
The judgment of the en banc court of appeals was entered on March 23, 2023. On June 9, 2023, Justice Alito
(1)
2
extended the time within which to file a petition for a
writ of certiorari to and including July 21, 2023. The
jurisdiction of this Court is invoked under 28 U.S.C.
1254(1).
STATUTORY PROVISIONS INVOLVED
Pertinent statutory provisions are set forth in the
appendix to this petition. App., infra, 160a-161a.
STATEMENT
A. Civil Service Background
1. The President is responsible for superintending
the federal workforce. “Under our Constitution, the
‘executive Power’—all of it—is ‘vested in a President,’
who must ‘take Care that the Laws be faithfully executed.’ ” Seila Law LLC v. CFPB, 140 S. Ct. 2183, 2191
(2020) (quoting U.S. Const. Art. II, § 1, Cl. 1; id. § 3).
The President’s powers include “the general administrative control of those executing the laws.” Free Enter.
Fund v. Public Co. Accounting Oversight Bd., 561 U.S.
477, 492 (2010) (citation omitted).
Consistent with the President’s constitutional role as
“Chief Executive,” Free Enter. Fund, 561 U.S. at 493
(citation omitted), Congress has authorized him to “prescribe such regulations for the admission of individuals
into the civil service in the executive branch as will best
promote the efficiency of that service” and to “ascertain
the fitness of applicants,” including specifically their
“health.” 5 U.S.C. 3301(1) and (2). Congress has also
authorized the President to establish “rules governing
the competitive service,” 5 U.S.C. 3302, as well as
3
exceptions to competitive hiring, i.e., rules for the excepted service, 5 U.S.C. 3302(1). 1
In addition to his authority over the admission of new
employees into federal service, the President has long
had express statutory authority to “prescribe regulations for the conduct of employees in the executive
branch.” 5 U.S.C. 7301; see Act of Mar. 3, 1871, ch. 114,
§ 9, 16 Stat. 514-515. Presidents have relied on that authority to establish a wide array of rules for federal employees. In 1986, for example, President Reagan invoked Section 7301 to require drug-testing for sensitive
positions in the civil service after he determined that
any use of illegal drugs, “whether on duty or off duty, is
contrary to the efficiency of the service.” Exec. Order
No. 12,564, § 1(b), 3 C.F.R. 224, 225 (1986 Comp.). Presidents have also issued several executive orders, including most recently in 1989, establishing ethics rules for
federal employees based in part on Section 7301 or its
predecessors. See, e.g., Exec. Order No. 12,674, 3 C.F.R.
215 (1990 Comp.).
2. An employee in the competitive or excepted service generally may be removed for “such cause as will
promote the efficiency of the service.” 5 U.S.C. 7513(a);
cf. 5 U.S.C. 7543(a) (Senior Executive Service). Under
the Civil Service Reform Act of 1978 (CSRA), Pub.
L. No. 95-454, 92 Stat. 1111, specified non-probationary
employees in the competitive or excepted service have
Federal civilian employees are classified into three main categories: the “Senior Executive Service,” which is a relatively small cadre of high-level employees, 5 U.S.C. 3132(a)(2); the “competitive
service,” which consists of other “civil service positions in the executive branch” not exempted from competitive-hiring requirements,
5 U.S.C. 2102(a)(1); and the “excepted service,” covering positions
not in the first two categories, 5 U.S.C. 2103(a).
1
4
a “right to notice, representation by counsel, an opportunity to respond, and a written, reasoned decision from
the agency” before any removal. Elgin v. Department
of the Treasury, 567 U.S. 1, 6 (2012). If the agency proposes to remove a covered employee or take any of the
other adverse personnel actions specified in 5 U.S.C.
7512, such as a suspension of more than 14 days, “the
CSRA gives the employee the right to a hearing * * *
before the Merit Systems Protection Board (MSPB).”
Elgin, 567 U.S. at 6 (citing 5 U.S.C. 7513(d), 7701(a)(1)(2)). The MSPB is an adjudicative agency with the authority to “order relief to prevailing employees, including reinstatement, backpay, and attorney’s fees.” Ibid.
The Federal Circuit, in turn, has “exclusive jurisdiction” over appeals from the MSPB’s decisions, 28 U.S.C.
1295(a)(9), except in certain cases involving discrimination claims, see 5 U.S.C. 7703(b).
The procedures established by the CSRA for review
of covered personnel actions are comprehensive and exclusive. This Court has held that if Congress declined
to extend the CSRA’s “integrated scheme of administrative and judicial review” to a particular class of federal employees, United States v. Fausto, 484 U.S. 439,
445 (1988), those employees do not have a “statutory entitlement” to judicial review in any forum “for adverse
action of the type governed by” the CSRA, id. at 448449. And “[ j]ust as the CSRA’s ‘elaborate’ framework
demonstrates Congress’s intent to entirely foreclose judicial review to employees to whom the CSRA denies
statutory review, it similarly indicates that extrastatutory review is not available to those employees to whom
the CSRA grants administrative and judicial review.”
Elgin, 567 U.S. at 11 (citation omitted).
5
B. Executive Order 14,043
This case concerns an executive order issued by the
President during the throes of the COVID-19 pandemic.
On September 9, 2021, after the Food and Drug Administration approved the first COVID-19 vaccine, the
President ordered each agency in the Executive Branch
to “implement, to the extent consistent with applicable
law, a program to require COVID-19 vaccination for all
of its Federal employees.” Exec. Order No. 14,043 (EO
14,043), § 2, 86 Fed. Reg. 50,989, 50,990 (Sept. 14, 2021).
The order directed agencies to provide for exceptions
“as required by law,” ibid., including on the basis of
medical conditions or sincerely held religious beliefs.
The order rested on and invoked the President’s
constitutional and statutory authority to manage the civilian workforce, including 5 U.S.C. 3301, 3302, and
7301. The President explained that “[t]he health and
safety of the Federal workforce, and the health and
safety of members of the public with whom they interact, are foundational to the efficiency of the civil service.” EO 14,043, § 1, 86 Fed. Reg. at 50,989. He also
noted that, according to the Centers for Disease Control and Prevention (CDC), vaccination was the single
“best way to slow the spread of COVID-19” and to prevent infection from the then-prevalent Delta variant.
Ibid. Accordingly, the President determined that requiring “COVID-19 vaccination for all Federal employees” was necessary “to promote the health and safety of
the Federal workforce and the efficiency of the civil service.” Ibid.
At that time, thousands of Americans were dying
from COVID-19 each week. See CDC, COVID Data
Tracker, go.usa.gov/xeFyx. Millions of Americans were
missing work “because they had COVID-19 or were
6
caring for someone with COVID-19.” The White House,
White House Report: Vaccination Requirements Are
Helping Vaccinate More People, Protect Americans
from COVID-19, and Strengthen the Economy 4 (Oct. 7,
2021) (Vaccination Report). The federal government,
like other employers, was forced to significantly alter
its operations in response to the pandemic—reducing
in-person work, limiting official travel, and taking other
precautions to reduce the risk that employees would
contract COVID-19, or transmit the disease to others,
while carrying out their official duties and functions.
See, e.g., Pandemic Response Accountability Comm.,
Top Challenges Facing Federal Agencies: COVID-19
Emergency Relief and Response Efforts 8-9, 25, 45
(June 2020). Numerous private-sector businesses—
including major employers like United Airlines, Tyson
Foods, AT&T, Bank of America, and CVS—likewise responded to the pandemic by requiring their employees
to be vaccinated. See Vaccination Report 9, 12.
The President directed the Safer Federal Workforce
Task Force to issue guidance to implement the vaccination requirement. EO 14,043, § 2, 86 Fed. Reg. at 50,990;
see Exec. Order No. 13,991, § 4, 86 Fed. Reg. 7045, 7046
(Jan. 25, 2021) (earlier order establishing the Task
Force). The Task Force issued guidance confirming the
availability of medical and religious accommodations
and providing a timeline for compliance. The guidance
set an initial deadline in November 2021 for non-exempt
employees to be fully vaccinated, though that deadline
was “later postponed * * * to early 2022.” App., infra,
105a. The guidance also instructed agencies to use progressive discipline, under which employees who failed
to comply would first receive counseling and education
7
followed by sanctions of “escalating” severity, including
reprimands, suspension, and termination. Ibid.
C. The Present Controversy
1. This suit is a challenge to EO 14,043 filed in the
U.S. District Court for the Southern District of Texas
in December 2021. The plaintiffs, respondents here, are
a recently formed membership organization known as
Feds for Medical Freedom, along with a local union
chapter, a federal contractor, and dozens of individual
federal employees. See Compl. ¶¶ 11-76.2 Respondents
alleged that several of the employee plaintiffs had declined to comply with the vaccination requirement and
had been “disciplined with written reprimands and
warnings” and, in one instance, notice that the plaintiff
would be terminated in January 2022. Compl. ¶ 147.
The gravamen of respondents’ challenge was that the
requirement for federal employees to be vaccinated
against COVID-19 as a condition of employment was
“ultra vires.” Compl. ¶ 164.
2. On January 21, 2022, the district court entered a
preliminary injunction forbidding the federal government from implementing or enforcing EO 14,043
against any federal employee nationwide. App., infra,
140a-157a. The court rejected the government’s argument that the CSRA precluded respondents from bringing a pre-enforcement challenge to the vaccination requirement in district court. Id. at 143a-145a. The court
reasoned that the CSRA’s provisions for review by the
The individual plaintiffs included some employees of federal contractors, and respondents also challenged a separate executive order regarding COVID-19 safety protocols for federal contractors.
That order is not at issue here. See App., infra, 141a-142a (district
court’s order declining to address the contractor executive order in
light of developments in other litigation).
2
8
MSPB and the Federal Circuit apply to “actual discipline,” id. at 144a, and have no preclusive effect when
employees preemptively challenge “government-wide
policies” before suffering any such discipline, id. at 145a
n.3. On the merits, the court concluded that respondents were likely to succeed in showing that the President’s authority to prescribe regulations for the conduct
of federal employees permitted him to regulate only
“workplace conduct,” and that the vaccination requirement exceeded that authority. Id. at 151a.
In the single paragraph of its opinion devoted to the
scope of the injunction, the district court stated that
Feds for Medical Freedom “has more than 6,000 members spread across every state * * * and is actively adding new members,” such that relief limited to the parties would be “ ‘unwieldy.’ ” App., infra, 156a (citation
omitted). The court declined to stay its injunction pending appeal. Id. at 138a-139a.
3. The government moved for a stay pending appeal
in the Fifth Circuit. A divided motions panel declined
to grant a stay, determining that the government’s motion should be carried with the case for disposition by a
merits panel. App., infra, 124a-137a. A divided merits
panel then vacated the preliminary injunction and remanded to the district court with instructions to dismiss
the case for lack of jurisdiction based on the CSRA. Id.
at 103a-123a. Respondents sought rehearing, which delayed issuance of the mandate and thus kept the preliminary injunction in effect. See Fed. R. App. P. 41(b). In
June 2022, the court of appeals granted rehearing en
banc. App., infra, 158a-159a.
The en banc court of appeals ultimately affirmed the
preliminary injunction, with seven judges dissenting in
whole or part. App., infra, 1a-102a. The majority held
9
that the CSRA did not preclude the district court from
exercising jurisdiction over respondents’ challenge. Id.
at 3a-4a. The majority acknowledged that “the CSRA
eliminates [28 U.S.C.] 1331 jurisdiction” when a federal
employee seeks to challenge a “personnel action[] covered by the CSRA,” such as a termination. Id. at 8a. In
the majority’s view, however, the CSRA did not preclude respondents from preemptively challenging the
vaccination requirement in district court on the theory
that the requirement was not itself a “CSRA-covered
personnel action.” Id. at 14a. The majority also stated
that any future adverse personnel actions for refusing
to comply with the vaccination requirement were
merely “hypothetical” and were therefore irrelevant to
the jurisdictional question. Id. at 19a.
The en banc majority addressed the CSRA issue at
length. See App., infra, 3a-39a. With respect to the
merits, however, the majority stated only that it “substantially agree[d]” with the district court’s reasoning
and that it was “unpersuaded” by the government’s arguments on appeal. Id. at 40a. The majority also stated
that the district court did not abuse its discretion in extending the injunction to every federal employee nationwide. Id. at 41a.
Judge Ho, joined by Judge Jones, concurred in the
judgment but wrote separately to express the view that
statutory limits on the President’s authority to remove
civilian employees violate Article II—an issue he found
not squarely presented here. App., infra, 45a-52a.
Judge Haynes concurred in the judgment in part and
dissented in part. App., infra, 53a-56a. She largely
agreed with the majority but would have limited the
scope of the injunction to the parties. See id. at 56a.
10
Judge Higginson, joined by Judge Southwick, concurred in part and dissented in part. App., infra, 57a97a. In his view, the majority had failed to appreciate
that the “whole point of this lawsuit is to challenge
CSRA-covered personnel actions.” Id. at 75a. Judge
Higginson also criticized the majority for creating a
“loophole,” id. at 77a n.10, under which employees who
wish to avoid the CSRA review scheme may instead sue
in district court before suffering any adverse personnel
action, stating that such an understanding of CSRA preclusion “would let plaintiffs end run” this Court’s precedent, id. at 78a (discussing Elgin, 567 U.S. at 7, and
Fausto, 484 U.S. at 441). Although Judge Higginson
would have recognized an exception permitting districtcourt jurisdiction over some of respondents’ constitutional claims, id. at 80a-81a, he would have held that
those claims lack merit, id. at 88a-97a.
Judge Stewart, joined by Chief Judge Richman and
Judges Dennis and Graves, dissented. App., infra, 98a102a. For the reasons given by the merits panel, those
judges would have held that the CSRA entirely “precludes district court review” of challenges to EO 14,043.
Id. at 98a.3
D. Subsequent Developments
The en banc court of appeals entered judgment on
March 23, 2023. App., infra, 1a. On April 10, 2023, the
President signed into law a joint resolution enacted by
Congress to terminate the national emergency
The district court had held the case in abeyance pending the government’s appeal. After the Fifth Circuit’s decision, respondents
moved to reopen the litigation and for entry of summary judgment
and a permanent injunction. See D. Ct. Doc. 49, at 1 (May 12, 2023).
The district court has not yet acted on that motion.
3
11
concerning COVID-19. Act of Apr. 10, 2023, Pub. L. No.
118-3, 137 Stat. 6; see 88 Fed. Reg. 9385, 9385 (Feb. 14,
2023). In the following weeks, the government took a
number of steps to wind down emergency measures that
had been put into place to address the acute phase of
the pandemic.
As particularly relevant here, the President revoked
EO 14,043—the order at issue in this case—on May 9,
2023. See Exec. Order No. 14,099 (EO 14,099), § 2, 88
Fed. Reg. 30,891, 30,891 (May 15, 2023). In doing so,
the President explained that he had issued EO 14,043
“when the highly contagious B.1.617.2 (Delta) variant
was the predominant variant of the virus in the United
States and had led to a rapid rise in cases and hospitalizations.” Id. § 1, 88 Fed. Reg. at 30,891. He further
explained that the government had “achieved a 98 percent” rate of compliance with EO 14,043 and that more
than 270 million Americans had become vaccinated in
“the largest adult vaccination program in the history of
the United States.” Ibid. The President also noted
that, since he had issued EO 14,043 in September 2021,
“COVID-19 deaths ha[d] declined by 93 percent, and
new COVID-19 hospitalizations ha[d] declined by 86
percent.” Ibid. Citing that progress, the President determined that “we no longer need a Government-wide
vaccination requirement for Federal employees.” Ibid.
The President accordingly revoked EO 14,043 and
directed that “[a]gency policies adopted to implement
[EO 14,043], to the extent such policies are premised
on” that order, “no longer may be enforced and shall be
rescinded consistent with applicable law.” EO 14,099,
§ 2, 88 Fed. Reg. at 30,891. The revocation of EO 14,043
took effect on May 12, 2023. Id. § 3, 88 Fed. Reg. at
30,891.
12
REASONS FOR GRANTING THE PETITION
The Fifth Circuit wrongly held that respondents may
circumvent the comprehensive and exclusive scheme of
administrative and judicial review established by the
Civil Service Reform Act (CSRA) by preemptively suing in district court. The Fifth Circuit then compounded its jurisdictional error by upholding a nationwide preliminary injunction forbidding the government
from implementing EO 14,043. The Fifth Circuit gave
virtually no justification for that extraordinary relief,
which frustrated an important policy adopted by the
President pursuant to his express statutory authority to
superintend the federal civilian workforce.
The decision below would have warranted review by
this Court for multiple reasons, including that the Fifth
Circuit’s holding on CSRA preclusion squarely conflicts
with a D.C. Circuit decision addressing the same question in another challenge to EO 14,043. See Payne v.
Biden, 62 F.4th 598 (D.C. Cir. 2023), petition for cert.
pending, No. 22-1225 (filed June 16, 2023). But before
the government could obtain further review, the President revoked EO 14,043 in light of changed public
health conditions and this appeal became moot. Consistent with this Court’s ordinary practice under such
circumstances, the Court should grant the petition for a
writ of certiorari, vacate the judgment below, and remand with instructions to direct the district court to dismiss its order granting a preliminary injunction as
moot. See United States v. Munsingwear, Inc., 340
U.S. 36, 39 (1950); see also, e.g., Mayorkas v. Innovation Law Lab, 141 S. Ct. 2842, 2842 (2021).4
The plaintiff in Payne has filed a petition for a writ of certiorari
seeking Munsingwear vacatur of the D.C. Circuit’s decision in that
case. See Pet. at i, 8-11, Payne, supra (No. 22-1225). The
4
13
A. This Appeal Is Moot
The nationwide preliminary injunction issued by the
district court and the government’s appeal from that injunction became moot when the President revoked EO
14,043.
1. Under Article III, the jurisdiction of the federal
courts is limited to the resolution of actual “Cases” or
“Controversies.” U.S. Const. Art. III, § 2, Cl. 1. “To
qualify as a case fit for federal-court adjudication, ‘an
actual controversy must be extant at all stages of review.’ ” Arizonans for Official English v. Arizona, 520
U.S. 43, 67 (1997) (citation omitted). “A case that becomes moot at any point during the proceedings is ‘no
longer a “Case” or “Controversy” for purposes of Article III,’ and is outside the jurisdiction of the federal
courts.” United States v. Sanchez-Gomez, 138 S. Ct.
1532, 1537 (2018) (quoting Already, LLC v. Nike, Inc.,
568 U.S. 85, 91 (2013)).
A case or appeal becomes moot “when the issues presented are no longer ‘live’ or the parties lack a legally
cognizable interest in the outcome.” Already, 568 U.S.
at 91 (citation omitted). “No matter how vehemently
the parties continue to dispute the lawfulness of the conduct that precipitated the lawsuit, the case is moot if the
dispute ‘is no longer embedded in any actual controversy about the plaintiffs’ particular legal rights.’ ”
Ibid. (citation omitted).
Under those principles, this preliminary-injunction
appeal became moot when the President revoked EO
14,043 and eliminated the basis for any agency policies
premised on EO 14,043, such as the Safer Federal
government agrees that Munsingwear vacatur is warranted there
for the same reasons that it is warranted here and will convey that
position in its response brief.
14
Workforce Task Force’s guidance. The issues presented in the government’s interlocutory appeal to the
Fifth Circuit, including whether the district court
lacked jurisdiction to preliminarily enjoin the implementation of EO 14,043 and whether the preliminary injunction was an abuse of discretion, are no longer the
subject of any live controversy. EO 14,043 no longer
exists to be enjoined. Affirming the preliminary injunction would do nothing to benefit respondents, and they
therefore lack any legally cognizable interest in the outcome of these proceedings.
2. In the district court, respondents have contended
that this case is not moot because “the President voluntarily ceased the offending conduct.” D. Ct. Doc. 49, at 14
(May 12, 2023). Respondents’ reliance on the voluntarycessation exception to mootness is misplaced.
This Court has “recognized * * * that a defendant
cannot automatically moot a case simply by ending its
unlawful conduct once sued.” Already, 568 U.S. at 91.
Otherwise, defendants would be able to “evade judicial
review” in Article III courts “by temporarily altering
questionable behavior,” only to resume the challenged
conduct at a later time. City News & Novelty, Inc. v.
City of Waukesha, 531 U.S. 278, 284 n.1 (2001). “Given
this concern,” the Court has explained that “ ‘a defendant claiming that its voluntary compliance moots a case
bears the formidable burden of showing that it is absolutely clear the allegedly wrongful behavior could not
reasonably be expected to recur.’ ” Already, 568 U.S. at
91 (citation omitted).
Those principles confirm that the voluntary-cessation
exception does not apply here. The President revoked
EO 14,043 because of the waning of the pandemic, not
any effort to evade judicial review or gain litigation
15
advantage. The President explained that the country is
“no longer in the acute phase” of the COVID-19 pandemic. EO 14,099, § 1, 88 Fed. Reg. at 30,891. He noted
that hospitalization and mortality rates have fallen dramatically since EO 14,043 was issued, and that the vast
majority of civilian federal employees either are already
vaccinated or would be eligible for an exemption or extension under the terms of that order. Ibid. Accordingly,
the President determined that “we no longer need a
Government-wide vaccination requirement” to protect
the civilian federal workforce. Ibid.
The equitable exception for voluntary cessation does
not fit those circumstances. In Munsingwear, for example, this Court indicated than an analogous termination of a government policy in light of fundamentally
changed circumstances—there, the lifting of wartime
price controls after the end of the war—caused a pending dispute about the policy to become moot. See Munsingwear, 340 U.S. at 38-39. This Court also recently
concluded that the end of the COVID-19 public-health
emergency mooted a pending controversy about certain
border-control measures imposed during the pandemic,
notwithstanding the challengers’ argument that the
voluntary-cessation doctrine applied. See Arizona v.
Mayorkas, 143 S. Ct. 1312 (2023); Petitioners’ Ltr. at 13, Arizona, supra (May 16, 2023) (No. 22-592). And the
courts of appeals have likewise found that the recent lifting of various federal COVID-19 emergency measures
mooted disputes about those measures—including, in
one instance, another challenge to EO 14,043. See Donovan v. Vance, 70 F.4th 1167, 1172 (9th Cir. 2023)
(stating that the court “cannot provide” prospective injunctive relief “from EOs * * * that no longer exist”);
see also, e.g., Livingston Educ. Serv. Agency v. Becerra,
16
No. 22-1257, 2023 WL 4249469, at *1 (6th Cir. June 29,
2023); Health Freedom Def. Fund v. President of the
United States, No. 22-11287, 2023 WL 4115990, at *2-*4
(11th Cir. June 22, 2023); Missouri v. Biden, No. 221104, 2023 WL 3862561, at *1 (8th Cir. June 7, 2023) (per
curiam); Hollis v. Biden, No. 21-60910, 2023 WL
3593251, at *1 (5th Cir. May 18, 2023) (per curiam).
Even if revoking EO 14,043 in light of changed circumstances were viewed as akin to voluntarily ceasing
to enforce it, this controversy would still be moot because the President “could not reasonably be expected”
to reinstate EO 14,043. Already, LLC, 568 U.S. at 92
(citation omitted). A large majority of civilian federal
employees already chose to become vaccinated against
COVID-19. See EO 14,099, § 1, 88 Fed. Reg. at 30,891
(stating that the federal government had achieved “a 98
percent compliance rate,” taking into account approved
or pending exemptions). If the COVID-19 pandemic
were to reenter an acute phase posing heightened dangers to the public and the civilian federal workforce, any
policies adopted in response to those developments
would be based on and responsive to those new circumstances. Likewise, any future challenge to those hypothetical policies would have to take into account the circumstances justifying them. At this time, no reasonable
prospect exists that the government will resume enforcing the same policy challenged here.
B. The Decision Below Would Have Warranted Review
Vacatur of a lower court’s decision because of intervening mootness is generally available only to “those
who have been prevented from obtaining the review to
which they are entitled.” Camreta v. Greene, 563 U.S.
692, 712 (2011) (quoting Munsingwear, 340 U.S. at 39).
It has therefore been the longstanding position of the
17
United States that when a case becomes moot after the
court of appeals enters its judgment but before this
Court acts on a petition for a writ of certiorari, Munsingwear vacatur is appropriate only if the question
presented would have merited this Court’s review had
the case not become moot. See, e.g., Pet. at 16-17, Yellen
v. United States House of Representatives, 142 S. Ct.
332 (2021) (No. 20-1738); see also Stephen M. Shapiro et
al., Supreme Court Practice § 19.4, at 19-28 to 19-29 &
n.34 (11th ed. 2019). That standard is amply satisfied
here. Had this case not become moot, the Fifth Circuit’s
decision would have warranted this Court’s review because it squarely conflicts with a decision of the D.C.
Circuit, because it misapplies this Court’s CSRA precedent, and because it erroneously resolves important
questions of presidential authority and the proper scope
of equitable relief.
1. The Fifth Circuit held that the district court had
jurisdiction over respondents’ challenge to EO 14,043
notwithstanding the CSRA’s channeling provisions.
See App., infra, 3a-21a. That holding directly conflicts
with the D.C. Circuit’s decision in a parallel case, Payne
v. Biden, supra.
a. In Payne, the D.C. Circuit unanimously affirmed
the dismissal of a challenge to EO 14,043 on CSRA preclusion grounds. 62 F.4th at 600. The plaintiff in that
case was a civilian federal employee who alleged that
EO 14,043 “violate[d] the separation of powers.” Id. at
602. Like respondents, the employee sued the government in district court before being suspended or terminated for refusing to comply with EO 14,043. See id. at
604. The district court determined that the plaintiff ’s
claims were “precluded under the CSRA” and therefore
18
“dismissed the suit for lack of subject matter jurisdiction.” Id. at 600.
In affirming, the D.C. Circuit explained that the
CSRA sets forth comprehensive procedures for federal
employees to challenge “major adverse [personnel] actions,” including removal from the civil service. Payne,
62 F.4th at 601 (citing 5 U.S.C. 7511-7515). The D.C.
Circuit further explained that the CSRA generally
channels disputes about such actions “first to the MSPB
* * * and then to the Federal Circuit.” Ibid. The D.C.
Circuit also recognized that this Court has held that
“the CSRA’s ‘elaborate framework’ clearly ‘demonstrates Congress’ intent to entirely foreclose judicial review to employees to whom the CSRA denies statutory
review.’ ” Id. at 603 (quoting Elgin v. Department of the
Treasury, 567 U.S. 1, 11 (2012)).
The D.C. Circuit determined that the Payne plaintiff ’s challenge to EO 14,043 was “the type of claim Congress planned to be assessed under the CSRA,” 62
F.4th at 604, therefore precluding district-court jurisdiction. As particularly relevant here, the court rejected the plaintiff ’s attempt to characterize his challenge as an attack on the “vaccine mandate” writ large,
rather than an attempt to pretermit an eventual adverse personnel action, observing that “such re-framing
is inconsistent with his overarching argument and does
not alter the jurisdictional outcome.” Ibid.5
The Fourth Circuit reached the same conclusion in an unpublished decision from which the plaintiff did not seek further review. See Rydie v. Biden, No. 21-2359, 2022 WL 1153249, at *4-*8
(Apr. 19, 2022). Numerous district courts also dismissed challenges
to EO 14,043, including on CSRA preclusion grounds. See, e.g.,
Brass v. Biden, No. 21-cv-2778, 2022 WL 11732833, at *1 (D. Colo.
Oct. 20, 2022); American Fed’n of Gov’t Emps. Local 2586 v. Biden,
5
19
b. The D.C. Circuit’s decision in Payne cannot be
reconciled with the Fifth Circuit’s decision here. The
D.C. Circuit concluded that the CSRA precludes federal
employees from challenging EO 14,043 in district court.
The Fifth Circuit held in this case that a materially indistinguishable challenge to the exact same executive
order could be heard in district court.
That conflict would have warranted this Court’s
review under the Court’s traditional criteria. Sup. Ct.
R. 10(a). Indeed, further review would have been particularly warranted in light of the universal scope of the
preliminary injunction upheld by the Fifth Circuit. See
App., infra, 40a-44a. The Fifth Circuit effectively permitted a single district court to grant preliminary injunctive relief to the very same federal employees who
had been denied such relief in the D.C. Circuit case and
the numerous other decisions rejecting challenges to
EO 14,043. See p. 18 & n.5, supra. The en banc majority emphasized that those courts had denied relief on
threshold grounds like CSRA preclusion or lack of
standing, rather than on the merits. App., infra, 43a.
But that only underscores the division of authority: The
nationwide injunction upheld here effectively undid the
considered decisions of multiple other federal courts,
which had concluded that challenges to EO 14,043 must
be channeled through the mechanisms prescribed in the
CSRA.
2. The decision below also would have warranted
this Court’s review because the Fifth Circuit incorrectly
616 F. Supp. 3d 1275, 1280-1283 (W.D. Okla. 2022); American Fed’n
of Gov’t Emps. Local 2018 v. Biden, 598 F. Supp. 3d 241, 248-249
(E.D. Pa. 2022); cf. App., infra, 105a n.1 (vacated panel opinion) (observing that “[a]t least twelve district courts previously rejected
challenges to [EO 14,043] for various reasons”).
20
resolved multiple important questions of federal law.
The Fifth Circuit’s jurisdictional analysis cannot be
squared with this Court’s CSRA precedent, and its cursory evaluation of the merits wrongly discounted the
President’s statutory authority to establish regulations
governing the selection of new civilian federal employees and the conduct of existing employees.
a. This Court has made clear that the CSRA precludes federal employees from suing in district court to
challenge personnel actions covered by the Act. Those
precedents do not permit any exception for preemptive
challenges like this one.
In United States v. Fausto, 484 U.S. 439 (1988), a civilian federal employee was suspended from his job for
30 days without pay for misconduct. Id. at 442. The
Federal Circuit held that the CSRA did not preclude the
employee from suing for backpay because the CSRA did
not afford employees in his civil service category any
mechanism to challenge a 30-day suspension before the
MSPB or a court. Id. at 443. This Court reversed, reasoning that Congress’s “deliberate exclusion” of such
employees from the CSRA’s review provisions precluded
the plaintiff from seeking review by other means. Id. at
455. The Court observed that the CSRA establishes an
“elaborate” framework that “prescribes in great detail
the protections and remedies” available to specified federal employees for covered personnel actions. Id. at
443. The Court thus held that the absence of any provision for employees like the plaintiff to obtain judicial review was not an oversight but rather a “manifestation
of a considered congressional judgment” to deny such
employees any “entitlement to review.” Id. at 448-449.
The Court reaffirmed that view of CSRA preclusion
in Elgin, supra, which (unlike Fausto) involved federal
21
employees to whom the CSRA afforded review. See Elgin, 567 U.S. at 5-7. The employees were terminated
under a statute that prohibits Executive agencies from
employing individuals who “knowingly and willfully
failed to register” for the Selective Service when required to do so. Id. at 7 (citing 5 U.S.C. 3328). Rather
than pursuing the review mechanisms available to them
under the CSRA, the employees sought to challenge the
constitutionality of the employment bar in district
court. Id. at 7-8. This Court held that the CSRA “precludes district court jurisdiction over [the employees’]
claims.” Id. at 8. The Court explained that “[ j]ust as
the CSRA’s ‘elaborate’ framework demonstrates Congress’ intent to entirely foreclose judicial review to employees to whom the CSRA denies statutory review, it
similarly indicates that extrastatutory review is not
available to those employees to whom the CSRA grants
administrative and judicial review.” Id. at 11 (citation
omitted). The Court also explained that the CSRA does
not contain any exception for “facial * * * constitutional challenges.” Id. at 12.
The Fifth Circuit’s decision contradicts Fausto and
Elgin. Those precedents together make clear that, in
terms of administrative and judicial review of covered
personnel actions, what civilian federal employees “get
under the CSRA is what [they] get.” Fornaro v. James,
416 F.3d 63, 67 (D.C. Cir. 2005) (Roberts, J.). In the
decision below, however, the Fifth Circuit concluded
that respondents could avoid the reticulated CSRA
framework simply by suing in district court before suffering any “CSRA-covered personnel actions.” App.,
infra, 14a; see id. at 19a-21a. The Fifth Circuit stated
that CSRA preclusion “depend[s] on the claims plaintiffs choose to bring,” and it accepted respondents’
22
characterization of the claims at issue here as a challenge to the “vaccine mandate” itself, “separate and
apart from any personnel action.” Id. at 31a-32a.
That understanding of how the CSRA works would
permit federal employees to “end run [this Court’s]
precedent.” App., infra, 78a (Higginson, J., concurring
in part and dissenting in part). Under the logic of the
decision below, the plaintiffs in Elgin could have proceeded in district court by simply suing before being
terminated and framing their suit as a challenge to the
employment bar. Likewise, federal employees to whom
the CSRA denies any review could circumvent this
Court’s holding in Fausto by rushing to district court to
challenge any policy that the employees fear will result
in an otherwise-unreviewable personnel action.
Inviting such preemptive attacks would seriously undermine “[t]he CSRA’s objective of creating an integrated scheme of review” and would “reintroduce the
very potential for inconsistent decisionmaking and duplicative judicial review that the CSRA was designed to
avoid.” Elgin, 567 U.S. at 14. Congress did not enact
an “ ‘exhaustively detailed * * * system of review before the MSPB and the Federal Circuit’ only to leave
such a conspicuous (and unexplained) loophole.” Payne
v. Biden, 602 F. Supp. 3d 147, 160 (D.D.C. 2022) (brackets and citation omitted), aff ’d, 62 F.4th 598 (D.C. Cir.
2023), petition for cert. pending, No. 22-1225 (filed June
16, 2023).
b. The Fifth Circuit’s decision also would have warranted further review because the preliminary injunction upheld below wrongly circumscribed the President’s authority to superintend the federal civil service,
including his express authority under 5 U.S.C. 3301,
3302, and 7301. EO 14,043 was a lawful exercise of those
23
powers. The Fifth Circuit apparently concluded otherwise, but the en banc majority failed to explain why—
stating merely that it “substantially agree[d]” with the
district court’s reasoning. App., infra, 40a. The majority thus addressed an important question about presidential authority in a “perfunctory” “two sentences.”
Id. at 96a (Higginson, J., concurring in part and dissenting in part).
The district court’s reasoning was no more persuasive. The court stated that respondents were likely to
succeed in showing that EO 14,043 exceeded the President’s authority to “prescribe regulations for the conduct of employees in the executive branch,” 5 U.S.C.
7301, because, in the court’s view, Section 7301 only authorizes the President to regulate “workplace conduct,”
App., infra, 151a. But the court failed to justify that
italicized limitation, which appears nowhere in the statutory text. And even if the President’s authority under
Section 7301 were limited to prescribing regulations to
govern “workplace conduct,” ibid., the district court
identified no persuasive reason to regard EO 14,043 as
beyond the ambit of that authority. Numerous private
employers likewise responded to the COVID-19 pandemic by requiring their employees to be vaccinated as
a condition of employment. See p. 6, supra.
The district court did not discuss those private-sector
measures, any of the historical antecedents invoked by
the government, or the plain meaning of the term “conduct.” The district court instead reasoned that this
Court’s then-recent decision in NFIB v. OSHA, 142
S. Ct. 661 (2022) (per curiam), had already established
that “COVID-19 is not a workplace risk, but rather a
‘universal risk,’ ” App., infra, 151a (quoting NFIB, 142
S. Ct. at 665). But the statute at issue in NFIB
24
authorized the relevant agency to set occupational
safety and health standards for certain private businesses. NFIB, 142 S. Ct. at 665. This Court was not
addressing the President’s authority over the federal
workface that he himself superintends, nor was the
Court construing the term “conduct” as used in Section
7301 (or any other statute). The district court failed to
appreciate those distinctions.
EO 14,043 also rested in part on the President’s authority to prescribe “regulations for the admission of individuals into the civil service” and to “ascertain the fitness of applicants as to * * * health.” 5 U.S.C. 3301(1)
and (2); see EO 14,043 Pmbl., 86 Fed. Reg. at 50,989.
The district court dismissed Section 3301 as irrelevant
because the plaintiffs here are (or include) “current federal employees,” App., infra, 149a, yet the court proceeded to enjoin the government from enforcing EO
14,043 with respect to all federal employees—even new
entrants to the federal civil service—without any further discussion of Section 3301. The court also stated
that “other courts have already held that whatever authority the provision does provide is not expansive
enough to include a vaccine mandate,” ibid., citing a pair
of decisions addressing an entirely different Section
3301—namely, 41 U.S.C. 3301, a procurement statute
with no relevance to the President’s authority over federal employees. The Fifth Circuit, in turn, wholly failed
to address 5 U.S.C. 3301, let alone explain why it “substantially agree[d]” with the district court’s unreasoned
extension of the preliminary injunction to new employees. App., infra, 40a.
c. The universal scope of the preliminary injunction
further underscores that this Court’s review would have
been warranted.
Members of this Court have
25
repeatedly raised questions about the propriety of nationwide or “universal” injunctions, which lack any basis in Article III or traditional equitable principles. The
increasingly routine issuance of such injunctions has
“proven ‘unworkable, sowing chaos for litigants, the
government, courts, and all those affected by these
sometimes conflicting’ decrees.” United States v.
Texas, 143 S. Ct. 1964, 1980 (2023) (Gorsuch, J., concurring in the judgment) (quoting DHS v. New York, 140
S. Ct. 599, 600 (2020) (Gorsuch, J., concurring in the
grant of stay)) (brackets omitted); see Trump v. Hawaii, 138 S. Ct. 2392, 2425-2429 (2018) (Thomas, J., concurring).
This case is yet another example of those myriad
problems. Here, the district court’s issuance of sweeping nationwide relief to non-parties effectively overturned the results reached by numerous other courts,
including the D.C. and Fourth Circuits, which had rejected analogous challenges to EO 14,043. See pp. 1718 & n.5, supra. And the Fifth Circuit identified no
plausible justification for such extraordinary relief, instead accepting the district court’s view that more tailored relief would have been “unwieldy” or “confus[ing]” because Feds for Medical Freedom claims to
have more than 6000 members. App., infra, 41a (citation omitted). Neither of the lower courts explained
why an injunction limited to the parties would have been
any more “unwieldy” in this case than in any other case
involving an organizational plaintiff. At a minimum, the
nationwide scope of relief would have provided additional reason for this Court to grant review.
C. Vacatur Is Appropriate Under Munsingwear
When a case that would otherwise merit this Court’s
review becomes moot “while on its way [to this Court]
26
or pending [a] decision on the merits,” the Court’s “established practice” is to “vacate the judgment below and
remand with a direction to dismiss.” Munsingwear, 340
U.S. at 39. That practice ensures that no party is “prejudiced by a [lower-court] decision” and “prevent[s] a
judgment, unreviewable because of mootness, from
spawning any legal consequences.” Id. at 40-41; see
U.S. Bancorp Mortg. Co. v. Bonner Mall P’ship, 513
U.S. 18, 21 (1994) (“If a judgment has become moot
while awaiting review, this Court may not consider its
merits, but may make such disposition of the whole case
as justice may require.”) (brackets and citation omitted). The Court should follow that usual practice and
vacate the Fifth Circuit’s decision in this case.
As this Court has repeatedly observed, the determination whether to vacate the judgment when a case becomes moot while pending review ultimately “is an equitable one,” U.S. Bancorp, 513 U.S. at 29, requiring the
disposition that would be “most consonant to justice” in
light of the circumstances, id. at 24 (citation omitted).
See Azar v. Garza, 138 S. Ct. 1790, 1792 (2018) (per curiam) (observing that because Munsingwear vacatur “is
rooted in equity, the decision whether to vacate turns
on ‘the conditions and circumstances of the particular
case’ ”) (citation omitted).
The equities here favor vacatur. The case became
moot because the President revoked EO 14,043 as part
of a broader unwinding of measures that had been put
into place during the acute phase of the COVID-19 pandemic. No principle of equity would support requiring
the President to maintain the vaccination requirement,
despite his determination that it is now unnecessary,
merely to preserve the opportunity to ask this Court to
review the Fifth Circuit’s erroneous decision. It would
27
be especially strange to put the President to such a
choice in order to preserve the possibility that this
Court would reject the Fifth Circuit’s analysis of CSRA
preclusion—an issue with significant prospective importance to the Executive Branch, but no necessary
connection to vaccination or the COVID-19 pandemic.
This Court has observed that, absent “exceptional
circumstances,” vacatur may be unwarranted when “the
losing party has voluntarily forfeited his legal remedy
by the ordinary processes of appeal or certiorari,” such
as when “mootness results from settlement.” U.S. Bancorp, 513 U.S. at 25, 29; cf. id. at 25 n.3. But different
considerations apply when the mooting event is an action taken by a coordinate Branch in the exercise of authority and discretion vested in it by the Constitution
and statutes, apart from litigation. For example, in
United States v. Microsoft Corp., 138 S. Ct. 1186 (2018)
(per curiam), this Court vacated a lower court’s judgment after Congress passed and the President signed a
new statute, and the Executive Branch sought and obtained a new search warrant under the new statute—
the combination of which eliminated the “live dispute”
between the parties on “the issue with respect to which
certiorari was granted.” Id. at 1188. Similarly, in Alvarez v. Smith, 558 U.S. 87 (2009), the Court determined
that vacatur was appropriate even when the State had
voluntarily returned the disputed property to the respondents (thereby mooting the case), because the
State had done so for reasons unrelated to the federal
litigation. Id. at 96. Vacatur is equally appropriate
here, where the President revoked the vaccination requirement not for the purpose of mooting this case but
as part of a broader response to developments in public
health conditions unrelated to the litigation.
28
This Court’s recent practice further confirms that
Munsingwear vacatur is appropriate when challenges
to significant federal policies are mooted by Executive
actions undertaken in good faith and for reasons unrelated to litigation. See, e.g., Yellen v. United States
House of Representatives, 142 S. Ct. 332, 332 (2021)
(challenge to certain expenditures moot after Executive
Branch ceased the expenditures); Innovation Law Lab,
141 S. Ct. at 2842 (challenge to certain immigration
practices moot after Executive Branch terminated the
practices); cf. Trump v. International Refugee Assistance, 138 S. Ct. 353, 353 (2017) (challenge to executive
order moot after expiration of order). As in those cases,
neither justice nor the public interest would be served
by forcing the Executive Branch to choose between
maintaining a policy that it has concluded is no longer
warranted and acquiescing in a precedential judicial decision that the Executive Branch believes would be contrary to its prerogatives and harmful to the public interest as a whole.
29
CONCLUSION
The Court should grant the petition for a writ of certiorari, vacate the judgment of the court of appeals, and
remand with instructions to direct the district court to
vacate its order granting a preliminary injunction as
moot under United States v. Munsingwear, Inc., 340
U.S. 36 (1950).
Respectfully submitted.
ELIZABETH B. PRELOGAR
Solicitor General
BRIAN M. BOYNTON
Principal Deputy Assistant
Attorney General
BRIAN H. FLETCHER
Deputy Solicitor General
MATTHEW GUARNIERI
Assistant to the Solicitor
General
CHARLES W. SCARBOROUGH
SARAH CARROLL
CASEN B. ROSS
DANIEL WINIK
Attorneys
JULY 2023
APPENDIX
TABLE OF CONTENTS
Page
Appendix A
Appendix B
Appendix C
Appendix D
Appendix E
Appendix F
Appendix G
— Court of appeals en banc opinion
(Mar. 23, 2023) ......................................... 1a
— Court of appeals panel opinion
(Apr. 7, 2022) ...................................... 103a
— Court of appeals stay motion opinion
(Feb. 9, 2022) ..................................... 124a
— District court order denying stay
(Feb. 11, 2022) ................................... 138a
— District court memorandum opinion
and order (Jan. 21, 2022) .................. 140a
— Court of appeals order granting
en banc rehearing (June 27, 2022)..... 158a
— Statutory provisions:
5 U.S.C. 3301 ....................................... 160a
5 U.S.C. 3302 ....................................... 160a
5 U.S.C. 7301 ....................................... 161a
APPENDIX A
UNITED STATES COURT OF APPEALS
FOR THE FIFTH CIRCUIT
No. 22-40043
FEDS FOR MEDICAL FREEDOM; LOCAL 918, AMERICAN
FEDERATION OF GOVERNMENT EMPLOYEES;
HIGHLAND ENGINEERING, INCORPORATED;
RAYMOND A. BEEBE, JR.; JOHN ARMBRUST; ET AL.,
PLAINTIFFS-APPELLEES
v.
JOSEPH R. BIDEN, JR., IN HIS OFFICIAL CAPACITY AS
PRESIDENT OF THE UNITED STATES;
THE UNITED STATES OF AMERICA;
PETE BUTTIGIEG, IN HIS OFFICIAL CAPACITY AS
SECRETARY OF TRANSPORTATION ;
DEPARTMENT OF TRANSPORTATION ;
JANET YELLEN, IN HER OFFICIAL CAPACITY
AS SECRETARY OF TREASURY; ET AL.,
DEFENDANTS -APPELLANTS
[Filed:
Mar. 23, 2023]
Appeal from the United States District Court
for the Southern District of Texas
USDC No. 3:21-CV-356
Before: RICHMAN, Chief Judge, and JONES, SMITH,
BARKSDALE, STEWART, DENNIS, ELROD, SOUTHWICK,
HAYNES, GRAVES, HIGGINSON, WILLETT, HO, DUNCAN,
ENGELHARDT, OLDHAM, and WILSON, Circuit Judges.
(1a)
2a
ANDREW S. OLDHAM, Circuit Judge, joined by JONES,
SMITH, BARKSDALE, ELROD, WILLETT, HO, DUNCAN,
ENGELHARDT, and WILSON, Circuit Judges:*
The primary question presented is whether we have
jurisdiction over pre-enforcement challenges to President Biden’s vaccine mandate for federal employees.
We do. On the merits, we affirm the district court’s order.
I.
On September 9, 2021, President Biden issued Executive Order 14043, which generally required all federal
employees to be vaccinated. Employees who didn’t
comply would face termination. He also issued Executive Order 14042, imposing the same requirements and
punishments for federal contractors.
Feds for Medical Freedom is a non-profit organization with over 6,000 members employed by numerous
federal agencies and contractors. Feds for Medical
Freedom, along with a chapter of the American Federation of Government Employees and more than 50 individual plaintiffs, sued for declaratory and injunctive relief against the enforcement of both mandates.
Plaintiffs raised several constitutional and statutory
claims. First, they asserted constitutional objections.
They argued that the President did not have inherent
Article II authority to issue either mandate. And any
purported congressional delegation of such power violated either the major questions doctrine or the non* JUDGE WILLETT joins all except Part VI. JUDGE DOUGLAS
was not a member of the court when this case was submitted to the
court en banc and did not participate in this decision.
3a
delegation doctrine. Second, they claimed both mandates were arbitrary, capricious, and otherwise not in
accordance with law under the Administrative Procedure Act (“APA”). And the contractor mandate violated the APA because it was not in accordance with law.
Finally, they sought relief under the Declaratory Judgment Act (“DJA”).
The day after filing their complaint, plaintiffs sought
preliminary injunctions against both mandates. The
district court declined to enjoin the contractor mandate
because it was already the subject of a nationwide injunction. But it enjoined the employee mandate on
January 21, 2022. The Government timely appealed
that injunction.
On an expedited appeal, a divided panel of our court
vacated the injunction. See Feds for Medical Freedom
v. Biden, 30 F.4th 503 (5th Cir. 2022). The panel majority held “that the [Civil Service Reform Act of 1978
(“CSRA”)] precluded the district court’s jurisdiction.
Accordingly, the plaintiffs’ claim for preliminary injunctive relief fails because they have not shown a substantial likelihood of success on the merits. We do not
reach the parties’ arguments regarding the other requirements for a preliminary injunction.” Id. at 511.
JUDGE BARKSDALE dissented. We granted rehearing
en banc, vacating the panel opinion. See Feds for Medical Freedom v. Biden, 37 F.4th 1093 (5th Cir. 2022).
II.
“Jurisdiction is always first.” Carswell v. Camp, 54
F.4th 307, 310 (5th Cir. 2022) (quotation omitted).
Congress gave federal district courts jurisdiction over
“all civil actions arising under the Constitution, laws, or
4a
treaties of the United States.” 28 U.S.C. § 1331. It’s
undisputed that plaintiffs’ claims arise under federal
law, both constitutional and statutory. It’s also undisputed that the CSRA nowhere expressly repeals district
courts’ § 1331 jurisdiction over plaintiffs’ claims. The
Government’s contention, however, is that the CSRA
implicitly repeals § 1331 jurisdiction over plaintiffs’
claims.
Implicit jurisdiction-stripping turns on whether it’s
“fairly discernible” from the statutory scheme that Congress silently took away the jurisdiction that § 1331 explicitly conferred. “To determine whether it is ‘fairly
discernible’ that Congress precluded district court jurisdiction over petitioners’ claims, we examine the
CSRA’s text, structure, and purpose.” Elgin v. Dep’t
of Treasury, 567 U.S. 1, 10 (2012) (citations omitted).
We (A) begin with the CSRA’s text and structure.
Then we (B) discuss the statute’s purpose. Then we
(C) hold that the CSRA does not apply to the plaintiffs’
claims and hence does not implicitly displace § 1331 jurisdiction.
A.
We begin with the CSRA’s text and structure. The
CSRA’s “statutory framework provides graduated procedural protections depending on an [employment] action’s severity.” Kloeckner v. Solis, 568 U.S. 41, 44
(2012). Two parts of that graduated procedural framework are central to this case.
The first is codified at Chapter 23. See 5 U.S.C.
§§ 2301 et seq. Chapter 23 is the bottom of the CSRA’s
pyramid. It governs the least severe employment actions the Government can take and provides concomi-
5a
tantly fewer procedural protections and remedies for
federal employees aggrieved by those employment actions.
Specifically, Chapter 23 prohibits federal employers
from using a “prohibited personnel practice,” id.
§ 2302(a)(1), (b), to take a certain “personnel action,” id.
§ 2302(a)(2)(A). Chapter 23’s “prohibited personnel
practice[s]” include various forms of discrimination
(race, age, sex, &c.), nepotism, and retaliation for whistleblowing. See id. § 2302(b)(1) (discrimination), (b)(7)
(nepotism), (b)(8) (whistleblowing).
The triggering
“personnel action[s]” are limited to the following twelve
things:
(i)
an appointment;
(ii)
a promotion;
(iii) an action under chapter 75 of this title or other
disciplinary or corrective action;
(iv)
a detail, transfer, or reassignment;
(v)
a reinstatement;
(vi)
a restoration;
(vii)
a reemployment;
(viii) a performance evaluation under chapter 43 of
this title or under title 38;
(ix) a decision concerning pay, benefits, or awards,
or concerning education or training if the education
or training may reasonably be expected to lead to an
appointment, promotion, performance evaluation, or
other action described in this subparagraph;
6a
(x)
a decision to order psychiatric testing or examination;
(xi) the implementation or enforcement of any nondisclosure policy, form, or agreement; and
(xii) any other significant change in duties, responsibilities, or working conditions;
Id. § 2302(a)(2)(A). Chapter 23’s personnel actions obviously do not include severe measures such as demotions or terminations.1
Given that Chapter 23 applies only to relatively mild
personnel actions, Chapter 23’s review mechanisms are
also relatively modest. When a federal employee suffers a Chapter 23 “personnel action” based on a “prohibited personnel practice,” the employee can file an allegation with the Office of Special Counsel (“OSC”). Id.
§§ 1214(a), 2302. The OSC, in turn, can terminate the
matter or refer it to the Merit Systems Protection Board
(“MSPB”). Id. § 1214(a)(2) (termination), (b) (referSection 2302(a)(2)(A)(iii) (“romanette iii”) cross-references “an
action under chapter 75 of this title.” Chapter 75 does not use the
phrase “personnel action” but instead uses the phrase “an action.”
5 U.S.C. §§ 7502, 7512 (subchapter titles); see also id. § 7513(a), (b),
(d), (e) (referring to “an action” taken against a federal employee).
By virtue of romanette iii’s cross-reference, “personnel action” includes both a Chapter 23 personnel action and a Chapter 75 action.
Throughout this opinion, we use “Chapter 23 personnel actions” to
refer to the non-Chapter-75, less-severe employment actions listed
in § 2302. We use “Chapter 75 personnel actions” or “Chapter 75
actions” to refer to the more-severe employment actions such as
demotion and termination listed in § 7512. And unless context
dictates otherwise, we use “personnel actions” or “CSRA-covered
personnel actions” to include any employment actions covered by
the CSRA.
1
7a
ral). The employee can then seek judicial review of the
MSPB’s final order in the United States Court of
Appeals for the Federal Circuit.
Id. §§ 1214(c),
7703(b)(1)(A). Judicial review for Chapter 23 personnel actions is extremely limited, however. As thenJudge Scalia explained: “judicial scrutiny [is] limited,
at most, to insuring compliance with the statutory requirement that the OSC perform an adequate inquiry.”
Carducci v. Regan, 714 F.2d 171, 175 (D.C. Cir. 1983)
(quotation omitted).
The second part of the CSRA’s graduated procedural
framework is codified at Chapter 75. See 5 U.S.C.
§§ 7501 et seq. Chapter 75 forms the top of the CSRA’s
pyramid and governs the most-severe employment
actions—such as suspensions, reductions in pay, and
terminations. Id. §§ 7502, 7512(1)-(5). When the
Government proposes a suspension of fourteen days or
less, the covered employee is entitled to notice, the opportunity to respond, the right to an attorney, and the
right to a written decision. Id. § 7503(b)(1)-(4). When
the Government proposes any other Chapter 75 action,
the covered employee receives these same protections,
id. § 7513(b), and can also appeal to the MSPB, id.
§ 7513(d), and to the Federal Circuit, id. § 7703(b)(1)(A).
Where a covered employee challenges a covered personnel action, the CRSA’s review mechanisms are “exclusive.” Elgin, 567 U.S. at 13-14. Take for example
McAullife v. Rice, 966 F.2d 979 (5th Cir. 1992). There,
a CSRA-covered employee challenged the Chapter-75covered termination of her employment—but she tried
to do it in the Western District of Texas under the APA,
rather than in the MSPB and Federal Circuit under the
CSRA. See id. at 979. We rejected the attempt be-
8a
cause the CSRA provides the exclusive jurisdictional
(and remedial) font for covered federal employees when
they are challenging CSRA-covered personnel actions.
See ibid.
The italicized clause is very important for two reasons. First, the Supreme Court has been clear that the
CSRA eliminates § 1331 jurisdiction only for personnel
actions covered by the CSRA. For example, in United
States v. Fausto, 484 U.S. 439 (1988), the Court said the
CSRA “displays a clear congressional intent to deny the
excluded employees the protections of Chapter 75—
including judicial review—for personnel action covered
by that chapter.” Id. at 447 (emphasis added). Likewise in Elgin, the Court repeatedly limited its holding
to the CSRA’s jurisdictional effects on “a covered employee challeng[ing] a covered action,” 567 U.S. at 13; “a
covered employee’s appeal of a covered action,” ibid.;
and “a covered employee [attempting to] challenge a
covered employment action first in a district court,” id.
at 14 (all emphases added); see also id. at 10, 20-21
(reiterating the limitation).
The Court has never
suggested—much less held—that the CSRA implicitly
strips § 1331 jurisdiction over federal employees’ claims
outside the CSRA’s covered personnel actions. See
Bosco v. United States, 931 F.2d 879, 883 (Fed. Cir.
1991) (“The Supreme Court did not rule that the CSRA
provided the only means of judicial review of any actions
affecting federal employees, but rather that it was the
only means of review as to the types of adverse personnel action specifically covered by the CSRA. . . . ”
(emphases in original)).
9a
Second, the Court has expressly said the opposite—
that the CSRA does nothing to affect jurisdiction outside of its covered personnel actions:
Not all personnel actions are covered by this [CSRA]
system. For example, there are no provisions for
appeal of either suspensions for 14 days or less or adverse actions against probationary employees. In
addition, certain actions by supervisors against federal employees, such as wiretapping, warrantless
searches, or uncompensated takings, would not be
defined as ‘personnel actions’ within the statutory
scheme.
Bush v. Lucas, 462 U.S. 367, 385 n.28 (1983) (citations
omitted). In accordance with this express command,
federal courts across the country have time and again
held that the CSRA does not strip § 1331 jurisdiction
when federal employees challenge something other than
a CSRA-covered personnel action. For example, installing a hidden camera in the women’s changing area
of a VA medical center is not a CSRA-covered personnel
action and hence can be challenged outside the CSRA.
See Gustafson v. Adkins, 803 F.3d 883, 888 (7th Cir.
2015) (“Under the plain language of the statute, the term
‘personnel action’ does not encompass Adkins’s conduct
. . . [of] installing the hidden camera. . . . ”).
Same with assaulting a federal employee. See Orsay v.
DOJ, 289 F.3d 1125, 1131 (9th Cir. 2002), abrogated on
other grounds by Millbrook v. United States, 569 U.S.
50 (2013) (“Claxton’s alleged aiming of a loaded weapon
at Appellants does not fit any of the CSRA’s definitions
of ‘personnel action.’ Consequently, the CSRA does
not bar Appellants’ [Federal Tort Claims Act] claims.
. . . ”); Brock v. United States, 64 F.3d 1421, 1425 (9th
10a
Cir. 1995) (sexual assault). Same with libeling a federal employee. See Gutierrez v. Flores, 543 F.3d 248,
253-54 (5th Cir. 2008) (holding the CSRA does not apply
or strip jurisdiction because “this case does not involve
. . . any adverse employment action”). And same
with illegally searching a federal employee’s home.
See Collins v. Bender, 195 F.3d 1076, 1080 (9th Cir.
1999) (“[W]e do not believe that Congress intended to
deputize government supervisors as chieftains of security forces that police the private lives of their employees subject only to some administrative oversight, and
we do not believe that Congress meant to shoehorn into
the CSRA every odd occurrence where a supervisor
forms and leads such a renegade posse.”).
Consider for example the Third Circuit’s recent decision in Manivannan v. DOE, 42 F.4th 163 (3d Cir. 2022).
In that case, DOE attempted to fire a CSRA-covered
scientist and then allowed him to resign. Manivannan
sued DOE. Some of his claims challenged CSRAcovered personnel actions and hence could be brought
under only the CSRA (and not under § 1331). Id. at 173
(holding employee could challenge DOE’s internal investigation only under the CSRA because that investigation constituted a CSRA-covered “significant change
in working conditions”). But some of his claims were
not covered by the CSRA and hence could be brought in
the district court under § 1331. For example, DOE’s
“decision to disclose an employee’s records to state
prosecutors is not an adverse action” under Chapter 75
or a “personnel action” under Chapter 23.
Ibid.
Same with DOE’s conversion of Manivannan’s personal
property:
11a
Even construing the CSRA’s language broadly, we
fail to see how an employer’s alleged conversion of a
former employee’s personal property, unrelated to the
latter’s federal employment, constitutes a ‘disciplinary or corrective action,’ 5 U.S.C. § 2302(a)(2)(A)(iii),
a ‘significant change in duties, responsibilities, or
working conditions,’ id. § 2302(a)(2)(A)(xii), or any
other employment action set out in the statute.
Id. at 174.
In short, the text and structure of the CSRA creates
a decades-old, well-established, bright-line rule: Federal employees must bring challenges to CSRA-covered
personnel actions through the CSRA, but they remain
free to bring other, non-CSRA challenges under the district courts’ general § 1331 jurisdiction.
B.
The CSRA’s purpose reinforces this conclusion.
The CSRA was enacted “to replace the haphazard arrangements for administrative and judicial review of
personnel action, part of the ‘outdated patchwork of
statutes and rules built up over almost a century.’ ”
Fausto, 484 U.S. at 444 (quoting S. REP. NO. 95-969, at 3
(1978)). The old system created different grievance
rights for federal employees in different agencies; it entailed labyrinthine and uncertain administrative review
mechanisms that disincentivized managers from taking
disciplinary action even when clearly warranted. See
id. at 444-45 (citing S. REP. NO. 95-969, at 9 (1978)).
The CSRA “replaced the patchwork system with an integrated scheme of administrative and judicial review,
designed to balance the legitimate interests of the various categories of federal employees with the needs of
12a
sound and efficient administration.”
S. REP. NO. 95-969, at 4 (1978)).
Id. at 445 (citing
Thus, the CSRA’s purpose is to streamline and integrate the review system for federal employees’ challenges to personnel actions. It does nothing to promote that purpose to interpret the CSRA as stripping
§ 1331 jurisdiction over disputes beyond CSRA-covered
personnel actions. If anything, it would disserve the
CSRA’s purposes to rewrite it, as the Government requests, to strip jurisdiction over every claim any federal
employee could ever bring. That’s because the MSPB
has expertise in the byzantine procedures for taking and
challenging CSRA-covered personnel actions, but it
knows nothing about peephole cameras and wiretaps
and searches.
It would substantially burden the
MSPB to task it with such non-CSRA matters. And
more to the point, if Congress wanted to make the CSRA
process applicable to every claim an employee could
ever bring against a federal employer, it could’ve said
so. That would’ve made the CSRA less complicated by
obviating all the personnel-action limitations in Chapter
23 and Chapter 75—a road Congress plainly did not
take. See SAS Inst., Inc. v. Iancu, 138 S. Ct. 1348, 1357
(2018) (“We need not and will not invent an atextual explanation for Congress’s drafting choices when the statute’s own terms supply an answer.” (quotation omitted)).
The Government offers two responses. First, the
Government claims that allowing plaintiffs to bring suits
in district court would undermine the CSRA’s purpose
of creating “an integrated scheme of review.” Gov’t En
Banc Br. 22. The theory appears to be that federal employees can’t otherwise sue in district court, so it would
13a
undermine the integration of the MSPB and the Federal
Circuit to allow this case to get past the CSRA’s roadblocks. This contention is quite odd. As the Government well knows, one of the most common suits brought
by federal employees is the so-called “mixed case.” It’s
so-called because the employee mixes CSRA-covered
claims (for example, for CSRA-governed Chapter 75 violations) with non-CSRA claims (for example, for sex
discrimination under Title VII). See Kloeckner, 568
U.S. at 44-48 (describing mixed cases). Both Congress
and the Supreme Court say that federal employees are
free to bring their mixed cases in district court without
ever dealing with the MSPB or the Federal Circuit in
any way. See 5 U.S.C. § 7703(b)(2); Kloeckner, 568
U.S. at 50 (holding “mixed cases shall be filed in district
court”); see also Punch v. Bridenstine, 945 F.3d 322,
324-25 (5th Cir. 2019) (holding “the employee [bringing
a mixed case] need not start with the MSPB—or take
any of the roads running from it”—and instead can file
in district court). Thus, it’s simply not true that federal employees face an “integrated” grievance system
that never includes district court.
Second, the Government claims that it would create
a “gaping loophole” if employees could see a CSRAcovered personnel action coming down the pike and then
race to district court to invoke § 1331 jurisdiction before
it otherwise disappears. Gov’t En Banc Br. 22. Of
course it’s our job to interpret the words Congress actually wrote, not to entertain such policy arguments for
writing the CSRA differently.
See, e.g., Domino’s
Pizza, Inc. v. McDonald, 546 U.S. 470, 479 (2006). And
in any event, the Government’s policy concerns misunderstand the nature of plaintiffs’ claims. In a case like
this one, where plaintiffs are not challenging a CSRA-
14a
covered personnel action, § 1331 jurisdiction would not
disappear even if the Government took CSRA-covered
personnel actions against them. That’s why, for example, Manivannan could litigate his non-CSRA claims
even after incurring a CSRA-covered personnel action.
See Manivannan, 42 F.4th at 174. So there’s no race
to the courthouse because the plaintiff can stay in district court before or after the CSRA-covered personnel
action so long as he’s not challenging that CSRAcovered personnel action.
C.
The text, structure, and purpose of the CSRA all
show that it provides the exclusive review procedures
and employment remedies for CSRA-covered personnel
actions. The dispositive question therefore is whether
plaintiffs are challenging CSRA-covered personnel actions. If they are, they must channel their claims
through the CSRA; if they are not, their claims are cognizable in the district court.
We hold plaintiffs are not challenging CSRA-covered
personnel actions. Plaintiffs are challenging (under
the Constitution, the APA, and the DJA) the President’s
executive orders requiring federal employees to make
irreversible medical decisions to take COVID-19 vaccines. “Even construing the CSRA’s language broadly,
we fail to see how an employer’s” medical mandate could
constitute a covered personnel action. Ibid.
We (1) begin with Chapter 23.
Chapter 75.
Then we (2) discuss
1.
First, the Government fails to prove plaintiffs are
challenging a “personnel action” under Chapter 23.
15a
Neither § 2302(a)(2)(A)(xii) (“romanette xii”) nor
§ 2302(a)(2)(A)(iii) (“romanette iii”) applies to plaintiffs’
claims.
Romanette xii
Romanette xii is a residual clause that appears at the
end of a twelve-item list. After defining Chapter 23’s
“personnel action[s]” to include things such as appointments, promotions, and reassignments, Congress concluded the list by covering “any other significant change
in duties, responsibilities, or working conditions.”
5 U.S.C. § 2302(a)(2)(A)(xii). Such residual clauses
trigger “the maxim ejusdem generis, the statutory
canon that where general words follow specific words in
a statutory enumeration, the general words are construed to embrace only objects similar in nature to those
objects enumerated by the preceding specific words.”
Circuit City Stores, Inc. v. Adams, 532 U.S. 105, 114-15
(2001) (quotation omitted). All eleven of the personnel
actions that precede romanette xii are typical, everyday
employment decisions to, say, promote or reassign a single employee; none is an irrevocable decision that extends beyond the term of employment. See Turner v.
U.S. Agency for Glob. Media, 502 F. Supp. 3d 333, 367
(D.D.C. 2020) (“[C]ourts have determined that the term
‘working conditions’ generally refers to the daily, concrete parameters of a job, for example, hours, discrete
assignments, and the provision of necessary equipment
and resources.”).
Accordingly, we must interpret
romanette xii to refer to these discrete employment
decisions—not government-wide mandates that commandeer the personal medical decisions of every federal
employee. And we must interpret romanette xii to only
include conditions that last for the duration of the em-
16a
ployee’s job tenure—not mandated vaccinations that
have consequences long after the employee leaves the
federal workforce.
Moreover, it strains romanette xii’s text far beyond
its breaking point to say it includes permanent medical
decisions made outside the workplace. “[D]uties, responsibilities, or working conditions” plainly refer to duties, responsibilities, or working conditions of the employee’s workplace. 5 U.S.C. § 2302(a)(2)(A)(xii). It
doesn’t apply to personal medical choices. That result
follows a fortiori from Gustafson because if “working
conditions” does not include peephole cameras in workplace changing rooms, it certainly does not include private, irreversible medical decisions made in consultation
with private medical professionals outside the federal
workplace. See 803 F.3d at 888.
This interpretation of romanette xii is further reinforced by the Supreme Court’s decision in NFIB v.
OSHA, 142 S. Ct. 661 (2022) (per curiam). There, the
Court considered whether OSHA’s COVID-19 vaccine
mandate could constitute an “occupational safety and
health standard[].”
Id. at 665 (quoting 29 U.S.C.
§ 655(b)). The Court held no—both because “[w]e expect Congress to speak clearly when authorizing an
agency to exercise powers of vast economic and political
significance,” and because workplace-safety standards
refer to “hazards that employees face at work” and not
“day-to-day dangers that all face from crime, air pollution, or any number of communicable diseases.” Ibid.
(quotation omitted). Likewise here, Congress would
need to speak much more clearly than it did in
romanette xii if it wanted to strip § 1331 jurisdiction
over challenges to a mandate that extends to every sin-
17a
gle federal employee’s irreversible medical decisions.
Cf. Sistek v. Dep’t of Veterans Affs., 955 F.3d 948, 95456 (Fed. Cir. 2020) (holding Congress’s enumeration of
eleven specific personnel actions in the first eleven
clauses of § 2302(a)(2)(A) precludes interpreting the residual clause in romanette xii to include a modest retaliatory investigation of a single employee).
Romanette iii
Nor does romanette iii help the Government. It defines Chapter 23’s “personnel action[s]” to include “disciplinary or corrective action” against federal employees. 5 U.S.C. § 2302(a)(2)(A)(iii). But plaintiffs have
not received any “disciplinary or corrective action,” and
hence their claims do not challenge such actions. Some
plaintiffs received “letters of counseling” and “letters of
reprimand” for their failures to comply with the executive order. ROA. 1195-1202, 1204, 1206, 1212, 1216,
1229, 1232, 1242, 1244, 1486, 1493, 1745. But it’s well
settled that such letters are not “disciplinary or corrective action[s]” under the CSRA. See, e.g., Sistek, 955
F.3d at 955-57 (letter of reprimand was not a “personnel
action” under the CSRA); Graham v. Ashcroft, 358 F.3d
931, 933 (D.C. Cir. 2004) (Roberts, J.) (letter of censure
was not a “personnel action” under the CSRA). 2 AbThe circuits likewise have held that letters of reprimand and
other written warnings are not “materially adverse actions” in the
analogous Title VII context. See Durant v. D.C. Gov’t, 875 F.3d
685, 698 (D.C. Cir. 2017); Baloch v. Kempthorne, 550 F.3d 1191,
1199 (D.C. Cir. 2008) (Kavanaugh, J.); Medina v. Income Support
Div., N.M., 413 F.3d 1131, 1137 (10th Cir. 2005); Whitaker v. N. Ill.
Univ., 424 F.3d 640, 648 (7th Cir. 2005); Stewart v. Evans, 275 F.3d
1126, 1136 (D.C. Cir. 2002); Krause v. City of La Crosse, 246 F.3d
995, 1000 (7th Cir. 2001).
2
18a
sent any evidence of such action, the Government has no
basis to suggest plaintiffs’ claims are governed by
romanette iii.
And the Government all but concedes the point. In
its panel-stage brief, the Government obliquely suggests an employee could seek review under the CSRA
when he receives a letter of reprimand, but it never explains how or why such review comports with a wall of
contrary precedent from around the country. Moreover, the Government concedes that receipt of a letter is
merely “an early stage of [a] still-hypothetical progressive disciplinary process.”
Blue Br. 24 (emphasis
added). That concession all but proves that counseling
and reprimand letters do not trigger the CSRA’s review
provisions. And it’s telling that the Government abandons the point altogether in its later-filed briefs.3
2.
Second, the Government fails to prove that Chapter
75 implicitly strips the court of jurisdiction. As JUDGE
BARKSDALE noted in his panel dissent, the Government
has never argued that plaintiffs have suffered any of the
Chapter 75 personnel actions. See Feds for Medical
Freedom, 30 F.4th at 513 (Barksdale, J., dissenting).
And as JUDGE BARKSDALE correctly concluded, “[t]he
EO’s enactment . . . does not constitute an adverse
action subject to CSRA. The case at hand is instead a
pre-enforcement challenge to a government-wide policy,
imposed by the President, that would affect the million
Even if Chapter 23 did govern plaintiffs’ claims, it’s entirely
speculative to think plaintiffs could ever get them before a federal
court. See infra Part IV (discussing the OSC process).
3
19a
federal civilian workers, including the 6,000 members of
Feds for Medical Freedom.” Ibid.
In its en banc briefs, the Government does not contest JUDGE BARKSDALE’S premise; it effectively concedes that plaintiffs have not yet incurred reviewable
Chapter 75 employment actions. Rather, the Government (incorrectly) contests JUDGE BARKSDALE’s conclusion; it contends plaintiffs might one day incur Chapter 75 actions, and that alone should implicitly strip the
jurisdiction explicitly conferred by § 1331 today.
We disagree. “It is quite clear, that the jurisdiction
of the Court depends upon the state of things at the time
of the action brought, and that after vesting, it cannot
be ousted by subsequent events.” Mollan v. Torrance,
22 U.S. (9 Wheat.) 537, 539 (1824); see also Carr v. Alta
Verde Indus., Inc., 931 F.2d 1055, 1061 (5th Cir. 1991)
(“As with all questions of subject matter jurisdiction except mootness, standing is determined as of the date of
the filing of the complaint, and subsequent events do not
deprive the court of jurisdiction.”). And it’s equally
clear that we do not make jurisdictional determinations
based on hypothetical future facts. See, e.g., Clapper v.
Amnesty Int’l USA, 568 U.S. 398, 409-11 (2013) (rejecting attempt to make jurisdictional determinations based
on “[a]llegations of possible future injury” and “mere
speculation” about what the Government will do (quotation omitted)). Just as plaintiffs cannot invoke a district court’s jurisdiction based on speculation about
what the Government will do in the future, the Government cannot deny a district court’s jurisdiction based on
20a
speculation about what its employment supervisors will
do in the future. 4
Plaintiffs’ complaint does not challenge any personnel action reviewable under the CSRA. Nor does it
challenge any personnel action they could hypothetically incur in the future. Rather, plaintiffs claim that
the President’s vaccine mandate violates the U.S. Constitution and the APA. See Manivannan, 42 F.4th at
172 (“[W]hen assessing whether the CSRA bars federal
jurisdiction over an otherwise reviewable claim, courts
should look to the specific underlying conduct being
challenged to determine whether that conduct is an employment action covered by the statute.” (emphasis
The contrary rule would have untenable consequences. Consider, for example, the amount-in-controversy requirement for diversity jurisdiction under 28 U.S.C. § 1332. “Events occurring
subsequent to the institution of suit which reduce the amount recoverable below the statutory limit do not oust jurisdiction.” St.
Paul Mercury Indem. Co. v. Red Cab Co., 303 U.S. 283, 289-90
(1938). “[O]nce the district court’s jurisdiction is established,
subsequent events that reduce the amount in controversy to less
than $75,000 generally do not divest the court of diversity jurisdiction.”
Gebbia v. Wal-Mart Stores, Inc., 233 F.3d 880, 883
(5th Cir. 2000) (citations omitted). “Importantly, the jurisdictional facts must be judged as of the time the complaint is filed;
subsequent events cannot serve to deprive the court of jurisdiction
once it has attached.” St. Paul Reinsurance Co., Ltd. v. Greenberg, 134 F.3d 1250, 1253-54 (5th Cir. 1998) (citations omitted).
Yet on the Government’s theory here, a defendant could defeat diversity jurisdiction by saying: “We recognize plaintiffs properly
pleaded an amount in controversy of $75,001, but we’ll produce documents in discovery to show the real amount in controversy is
around $25,000.” Such future-hypothetical-fact arguments have
never been allowed to defeat (or create) subject matter jurisdiction.
4
21a
added)).5 The Government does not dispute that plaintiffs’ claims are ripe and otherwise cognizable under
§ 1331. And we can find nothing in the CSRA’s text,
structure, or purpose that implicitly displaces that jurisdiction for a claim outside the CSRA’s coverage. We
therefore hold that the district court properly exercised
its jurisdiction over plaintiffs’ claims.
III.
Our reading of the CSRA’s text, structure, and purpose is confirmed by precedent. A long line of cases
establishes that federal employees can bring facial, preenforcement actions against federal policies outside of
the CSRA.
For example, in NFFE v. Weinberger, 818 F.2d 935
(D.C. Cir. 1987), civilian federal employees sued to enjoin a directive establishing a “Drug Abuse Testing Program.” Id. at 937. The government argued that the
CSRA precluded pre-enforcement review in federal
court. Rejecting this argument, the court noted that
its decisions “have made it absolutely clear that civilian
federal employees may seek to enjoin government actions that violate their constitutional rights.” Id. at 940
(citation omitted).
NTEU v. Devine, 733 F.2d 114 (D.C. Cir. 1984), similarly rejected the government’s argument that the
JUDGE HIGGINSON points out that some members of Feds for
Medical Freedom may have incurred adverse personnel actions.
See post, at 66-67 & n.8 (Higginson, J., dissenting). That would
matter only if such actions could displace § 1331 jurisdiction that
otherwise attaches to claims that do not implicate the CSRA. See
supra, at 12 (rejecting this contention); accord Manivannan, 42
F.4th at 174.
5
22a
CSRA precludes jurisdiction over pre-enforcement challenges. The court held:
This claim is meritless. It is one thing to say that
when a statute provides a detailed scheme of administrative protection for defined employment rights,
less significant employment rights of the same sort
are implicitly excluded and cannot form the basis for
relief directly through the courts. It is quite different to suggest, as appellant does, that a detailed
scheme of administrative adjudication impliedly precludes preenforcement judicial review of rules.
Id. at 117 n.8 (citations omitted).
The Supreme Court has also, on multiple occasions,
entertained pre-enforcement challenges to laws or directives affecting federal employees without a word
about CSRA preclusion. See, e.g., NTEU v. Von Raab,
489 U.S. 656 (1989) (pre-enforcement challenge to drugtesting program for federal employees); United States
v. NTEU, 513 U.S. 454 (1995) (pre-enforcement challenge to a law prohibiting federal employees from accepting honoraria).
We have done the same. For example, in AFGE v.
FLRA, 794 F.2d 1013 (5th Cir. 1986), we cited Devine
for the proposition that a union of federal employees
would be able to bring a pre-enforcement challenge to
OPM regulations in district court. See id. at 1015-16.
Similarly, in NTEU v. Bush, 891 F.2d 99 (5th Cir. 1989),
we addressed the merits of a pre-enforcement suit challenging an executive order mandating drug testing for
federal employees. See id. at 100. We didn’t mention
CSRA preclusion, even though the claims in the suit centered on the CSRA. See ibid.
23a
The Government has two responses. First, it points
out that these cases predate Elgin, which according to
the Government, abrogated them. But as we recently
held in Cochran v. SEC, 20 F.4th 194 (5th Cir. 2021) (en
banc), cert. granted, 142 S. Ct. 2707 (2022), Elgin did not
“break new ground” regarding implicit preclusion. Id.
at 206. Nor did Elgin address pre-enforcement challenges at all. And the Government’s position entails
that Elgin held sub silentio that the Court lacked jurisdiction in all its past cases entertaining pre-enforcement
challenges to federal employment policies—including
Von Raab and United States v. NTEU. So Elgin can’t
support the weight the Government puts on it.
The Government’s other response is to claim that
most of these decisions involve “drive-by jurisdictional
rulings” on the scope of CSRA preclusion. Gray Br. 6
(quoting Steel Co. v. Citizens for a Better Env’t, 523 U.S.
83, 91 (1998)). That’s certainly not true of Weinberger
and Devine. In those cases, the D.C. Circuit carefully
considered and emphatically rejected the Government’s
theory of CSRA preclusion as “discredited” and “meritless.” Weinberger, 818 F.2d at 939-42; Devine, 733
F.2d at 117 n.8. So it’s no surprise that litigants and
courts gave it less-thorough consideration in later cases.
IV.
Because the CSRA’s text, structure, and purpose
foreclose the Government’s implicit-jurisdiction-stripping
theory, we need not proceed to an analysis of the factors
listed in Thunder Basin Coal Co. v. Reich, 510 U.S. 200
(1994). See Elgin, 567 U.S. at 10; Cochran, 20 F.4th at
204. But even if we reach them, those factors only confirm that the CSRA left intact the district court’s jurisdiction over this suit.
24a
The first Thunder Basin factor is whether “a finding
of preclusion could foreclose all meaningful judicial review.” 510 U.S. at 212-13. The Government contends
that plaintiffs have two avenues for meaningful judicial
review: Chapter 23 and the All Writs Act, 28 U.S.C.
§ 1651.
Chapter 23 provides no guarantee of judicial review
—much less a meaningful one. With exceptions not
relevant here,6 claims covered by Chapter 23 are vindicable only by OSC. And here’s how the OSC process
works: The employee first files a complaint with the
OSC. See 5 U.S.C. § 1214(a)(1)(A). If the OSC finds
“reasonable grounds” of a “prohibited personnel practice,” the OSC must report it to the employing agency,
MSPB, and OPM. Id. § 1214(b)(2)(B). If the agency
doesn’t fix the problem, the OSC “may petition” to the
MSPB. Id. § 1214(b)(2)(C) (emphasis added). And
only a final order from the MSPB is reviewable before
the Federal Circuit. See id. § 1214(c). This process
gives the OSC total and unfettered discretion to decide
whether to bring the claims before the MSPB. See
Krafsur v. Davenport, 736 F.3d 1032, 1034 (6th Cir.
2013) (“[I]f the Special Counsel . . . declines to refer
the case to the Board, the employee is out of luck. A
court may not review the Special Counsel’s decisions unless the Counsel has declined to investigate a complaint
at all.” (quotation omitted)). Its decisions not to purFor example, Congress created an “individual right of action”
in certain reprisal cases under § 2302(b)(8) and § 2302(b)(9)(A)(i),
(B), (C), and (D) that allows some employees to sue without OSC’s
involvement. See 5 U.S.C. §§ 1221, 1214(a)(3); Orr v. Dep’t of
Treasury, 83 M.S.P.R. 117 (1999). But the Government doesn’t argue that this exception, or any other, applies.
6
25a
sue claims are unreviewable. Cf. Heckler v. Chaney,
470 U.S. 821, 837 (1985) (prosecutorial discretion not reviewable).
This is not particularly surprising, given that Chapter 23 is the bottom of the CSRA’s pyramid and warrants the fewest procedural protections for federal
employees. See Carducci, 714 F.2d at 175. But the
narrowness of Chapter 23’s review provisions—and the
fact that any review at all turns on the unreviewable
discretion of Government officials—puts the lie to the
Government’s two-sentence suggestion that the OSC or
MSPB could or would give the plaintiffs relief against a
nationwide vaccine mandate. See Gov’t En Banc Br. 26
(so suggesting).
As for the Government’s invocation of the All Writs
Act, it proves both too much and too little. It’s too
much because the Government cannot explain how the
CSRA implicitly strips § 1331 jurisdiction but somehow
does not strip § 1651 jurisdiction. And all of the Government’s policy arguments about the former—that it
undermines the CSRA’s “integrated” review, creates a
“loophole,” &c.—apply equally to the latter. But the
Government’s reliance on the All Writs Act also proves
too little because as the Government itself concedes,
mandamus relief is a “drastic and extraordinary” remedy “reserved for really extraordinary causes.”
Cheney v. U.S. Dist. Ct. for D.C., 542 U.S. 367, 380 (2004)
(quotation omitted). So it’s hard to see how it provides
“meaningful review.” Moreover, as then-Judge Roberts noted for the D.C. Circuit, employees with CSRAcovered claims cannot avail themselves of the All Writs
Act. See Fornaro v. James, 416 F.3d 63, 69-70 (D.C.
Cir. 2005). So the only way the All Writs Act could ap-
26a
ply, on the Government’s own logic, is to hold that the
plaintiffs’ claims are outside the CSRA, thus obviating
the need for the All Writs Act in the first place. In all
events, the All Writs Act does not provide “meaningful
review” here.
The second Thunder Basin factor is whether plaintiffs’
claims are “wholly collateral” to the CSRA’s review provisions. 510 U.S. at 212 (quotation omitted). “[W]hether
a claim is collateral to the relevant statutory-review
scheme depends on whether that scheme is intended to
provide the sort of relief sought by the plaintiff.”
Cochran, 20 F.4th at 207.
This factor again cuts against stripping the district
court of jurisdiction. As detailed in Part II.A, the
CSRA scheme is a highly reticulated web of statutes and
regulations spanning multiple federal agencies (including the employee’s own, the OSC, the OPM, the EEOC,
and the MSPB) with overlapping procedural requirements and complicated substantive rules. See, e.g.,
Butler v. West, 164 F.3d 634, 637 (D.C. Cir. 1999) (describing it as a “complicated tapestry”). We’ve described the CSRA as a winding road which cannot be
driven by “the easily carsick.” Punch, 945 F.3d at 324.
The important point for present purposes, however, is
that individual federal employees are forced to navigate
it to air their individual grievances regarding individual
personnel actions. The standard fare for the MSPB’s
docket includes employee misconduct, hostile work environments, whistleblowing, and the like. No part of it
includes reviewing an executive order for compliance
with the APA or ordering injunctive relief that affects
thousands or millions of employees. No part of its byzantine procedures is suited for (or even appears to allow)
27a
an emergency preliminary injunction. And the Government does not cite a single case, nor have we found
one, where OSC agreed in its unreviewable discretion to
petition the MSPB for relief that remotely resembles
what plaintiffs request here.
The Government nevertheless contends plaintiffs’
claims are not wholly collateral to the CSRA because
what plaintiffs really want is to “avoid adverse employment action,” namely their terminations. Gov’t En
Banc Br. 17, 21-22. This is an untenable recharacterization of plaintiffs’ suit, which prayed to have a federal
court “[h]old unlawful and set aside the Federal Employee Mandate” and did not make specific employmentrelated claims. ROA. 138 (complaint). Declaring unlawful an executive order that requires millions of people to undergo a medical procedure is hardly “relief that
the CSRA routinely affords.” Elgin, 567 U.S. at 22.
The third Thunder Basin factor is whether the
claims at issue are “outside the agency’s expertise.”
510 U.S. at 212. As in Cochran, this case involves constitutional issues and “standard questions of administrative law, which the courts are at no disadvantage in answering.” 20 F.4th at 207-08 (quotation omitted). By
contrast, MSPB’s expertise lies in “ensur[ing] that Federal employees are protected against abuses by agency
management, that Executive branch agencies make employment decisions in accordance with the merit system
principles, and that Federal merit systems are kept free
of prohibited personnel practices.” MERIT SYSTEMS
PROTECTION BOARD, AN INTRODUCTION TO THE MERIT
SYSTEMS PROTECTION BOARD 5 (1999).
The Government doesn’t argue that plaintiffs’ claims
fall under the MSPB’s expertise. Rather, the Govern-
28a
ment argues that “the MSPB’s resolution of preliminary questions unique to the employment context could
obviate the need to address” plaintiffs’ claims. Gov’t
En Banc Br. 17 (quotation omitted) (emphasis added).
The Government provides no further support for this
claim, however, and we therefore hold that it’s forfeited.
Innova Hosp. San Antonio, Ltd. P’ship v. Blue Cross &
Blue Shield of Ga., Inc., 892 F.3d 719, 732 (5th Cir.
2018).
V.
JUDGE HIGGINSON’s dissent warrants a few additional words. He agrees that we have jurisdiction over
plaintiffs’ constitutional claims. Thus, thirteen of the
seventeen members of our en banc court agree that the
CSRA does not implicitly strip the jurisdiction that
§ 1331 explicitly confers on the district court to hear
plaintiffs’ constitutional claims. And eleven members
agree that the CSRA does not implicitly strip jurisdiction over any of plaintiffs’ claims, constitutional and
non-constitutional alike. But he disagrees with how we
reach that conclusion. We write to address these areas
of disagreement.
A.
As an initial matter, JUDGE HIGGINSON’s disagreement with the majority opinion is perplexing. On the
one hand, the dissenting opinion says “the CSRA does
not provide meaningful judicial review of the plaintiffs’
pre-enforcement challenge and [therefore] Congress
did not intend the CSRA to foreclose judicial review of
their separation-of-powers claim” against the vaccine
requirement, post, at 50 (Higginson, J., dissenting) (emphasis added), and “nothing in the CSRA shows that
29a
Congress meant to preclude federal jurisdiction to adjudicate separation-of-powers challenges to employment
policies set by the President,” id. at 76 (emphasis
added). On the other hand, the dissenting opinion
says, “Congress’s intent to preclude judicial review over
challenges to the [vaccine] requirement is fairly discernible within the statutory scheme,” id. at 63, “Congress’s
intent to preclude jurisdiction over pre-enforcement
challenges is fairly discernible in the statute,” id. at 64,
and “the only conclusion consistent with the text of the
[CSRA] and binding Supreme Court authority is that
Congress’s intent to preclude pre-enforcement challenges is fairly discernible in the CSRA,” id. at 69. It’s
difficult to reconcile these two positions.
The dissent tries to square that circle by arguing that
plaintiffs’ separation-of-powers challenges raise unique
constitutional concerns and thereby preclude Congress
from implicitly stripping § 1331 jurisdiction in this case.
See, e.g., id. at 75-76 & n.16. But it’s unclear where the
dissenting opinion would root its concerns in the Constitution or Supreme Court precedent. True, the Supreme Court has said the Constitution requires a federal forum for certain habeas claims, see Boumediene v.
Bush, 553 U.S. 723, 795 (2008), and takings claims, see
First Eng. Evangelical Lutheran Church of Glendale v.
Los Angeles Cnty., Cal., 482 U.S. 304, 315-19 (1987);
RICHARD H. FALLON, JR., JOHN F. MANNING , DANIEL J.
MELTZER & DAVID L. SHAPIRO, HART & WECHSLER’S
THE FEDERAL COURTS AND THE FEDERAL SYSTEM 330
(7th ed. 2015) [HART & WECHSLER]. But it’s well established that Congress need not provide a federal forum for constitutional claims more generally. To the
contrary, the first Congress did not create general federal question jurisdiction in the Judiciary Act of 1789, so
30a
all manner of constitutional claims were denied a federal
forum at the Founding without offending any constitutional principle. See HART & WECHSLER, supra, at 2526; Daniel J. Meltzer, The History and Structure of Article III, 138 U. PA. L. REV. 1569, 1585-93 (1990).7
Even if the dissenting opinion could identify a constitutional problem to be avoided, it then must identify an
alternative interpretation of the statutory text that
avoids it. See Nielsen v. Preap, 139 S. Ct. 954, 972
(2019) (“The trouble with this argument is that constitutional avoidance comes into play only when, after the application of ordinary textual analysis, the statute is
found to be susceptible of more than one construction.
The canon has no application absent ambiguity.” (quotation omitted)); Zadvydas v. Davis, 533 U.S. 678, 696
(2001) (“Despite this constitutional problem, if Congress
has made its intent in the statute clear, we must give
effect to that intent.” (quotation omitted)). But the
dissent raises no such plausible alternative reading. It
simply says there’s a constitutional problem of unknown
constitutional provenance, so plaintiffs must win to
If the dissenting opinion intends to ally itself with an Amarian
conception of Article III, § 2, clause 1—namely, that Congress
somehow must provide a federal forum for all cases arising under
federal law, see Akhil R. Amar, A Neo-Federalist View of Article
III: Separating the Two Tiers of Federal Jurisdiction, 65 B.U. L.
REV. 205 (1985)—then it proves too much. That’s because Article
III, § 2, clause 1 says the judicial power extends to “all Cases, in
Law and Equity, arising under this Constitution [and] the Laws of
the United States. . . . ” (emphasis added). The Amarian
view of Article III would require Congress to provide a federal forum for plaintiffs’ statutory APA claims, which the dissenting opinion expressly rejects. See post, at 70 n.12 (Higginson, J., dissenting) (arguing Congress can strip all jurisdiction over plaintiffs’
claims arising under the APA).
7
31a
avoid it. That’s a quite-odd form of constitutional
avoidance.
B.
Second, the dissent argues that the CSRA implicitly
strips § 1331 jurisdiction over CSRA-covered personnel
actions. See, e.g., post, at 54 (Higginson, J., dissenting). We agree. Elgin, Fausto, this majority opinion,
and the dissent all agree (quite clearly) that where the
CSRA applies, it implicitly strips the district court’s
§ 1331 jurisdiction. The question of course is whether
the CSRA applies.
And on that question, the dissent appears to say that
the CSRA applies to both personnel actions and preenforcement personnel actions. But this proposition
belies confusion over (1) what plaintiffs are challenging
and (2) what sort of jurisdiction the CSRA strips.
Plaintiffs are challenging the President’s vaccine
mandate—not any personnel action that may or may not
be taken in conjunction with that mandate. And the
CSRA’s implicit effects on jurisdiction depend on the
claims plaintiffs choose to bring. That’s why the CSRA
can apply when a plaintiff challenges his demotion or
termination under Chapter 75 and not apply when the
employee’s boss installs a hidden camera in a workplace
changing room. See supra, at 8. Thus, if the employee is subject to surveillance and then gets fired, she
has a multitude of claims. She might, for example,
challenge her termination—which would be subject to
the CSRA/MSPB process. But if the employee seeks
damages for the invasion of privacy itself, which is an
obvious injury separate and apart from the employment
action, that challenge does nothing to trigger the CSRA
32a
or to implicitly strip § 1331 jurisdiction. See Gustafson, 803 F.3d at 888; Bush, 462 U.S. at 385 n.28.
So it might be true, as the dissenting opinion sometimes suggests, that the CSRA would implicitly strip jurisdiction over an employee’s pre-termination suit to enjoin her termination (i.e., “pre-enforcement challenge to
a covered personnel action”). We take no position on
that because it’s irrelevant here. All that matters here
is that plaintiffs have identified an illegal vaccine mandate and, separate and apart from any personnel action
the President might one day take to enforce that illegal
order, the plaintiffs want judicial review of it. The
CSRA does nothing to implicitly strip jurisdiction over
these claims because the vaccine mandate itself is not a
personnel action—even if a future employer at some future time might take some future action to impose some
future personnel action on a future plaintiff who might
violate the mandate in the future.
C.
The dissenting opinion next says the vaccine mandate
itself is a “working condition” of federal employment.
That’s so, the dissent says, because romanette xii’s reference to “working conditions” is so capacious that it
includes—and hence channels into the MSPB—any significant change to any “circumstances under which an
employee performs his or her job.” Post, at 57 (Higginson, J., dissenting). Under the dissenting opinion’s
theory, it’s unclear there are any limits at all on what
the President could call a change in “working conditions.” But we know there are limits because the Supreme Court has said that warrantless searches and
wiretaps are so far afield from the CSRA’s list of personnel actions that they remain actionable in district
33a
court. See Bush, 462 U.S. at 385 n.28; see also Collins,
195 F.3d at 1080. And our sister circuits have said the
same thing about peephole cameras and assaults. See
Gustafson, 803 F.3d at 888; Brock, 64 F.3d at 1425; Orsay, 289 F.3d at 1131.
The dissenting opinion hazards no argument that an
employee’s irrevocable medical decision like the one at
issue here is somehow the employer’s prerogative in
ways that wiretaps, peephole cameras, and assaults are
not. Rather, the dissenting opinion contends that Congress contravened Bush v. Lucas (and Gustafson,
Brock, Orsay, and Collins by extension) when it added
romanettes x through xii to the CSRA. See post, at 5961 & n.5 (Higginson, J., dissenting). Those romanettes
bring under the CSRA “a decision to order psychiatric
testing or examination,” “the implementation or enforcement of any nondisclosure policy, form, or agreement,” and “any other significant change in duties, responsibilities, or working conditions.”
5 U.S.C.
§ 2302(a)(2)(A)(x)-(xii). They say nothing about wiretaps, peephole cameras, workplace assaults, or for that
matter irrevocable medical decisions. We cannot infer
that Congress’s decision to cover nondisclosure agreements under the CSRA brings with it an implied congressional decision to cover elephantine medical decisions in romanette xii’s ambiguous catchall phrase. To
conclude otherwise, “we would have to conclude that
Congress not only had hidden a rather large elephant in
a rather obscure mousehole, but had buried the ambiguity in which the pachyderm lurks beneath an incredibly
deep mound of specificity, none of which bears the footprints of the beast or any indication that Congress even
suspected its presence.” ABA v. FTC, 430 F.3d 457,
469 (D.C. Cir. 2005) (Sentelle, J.).
34a
Nor would it matter if the President ordered employees to make their irrevocable medical decisions “at
work.” Post, at 62 (Higginson, J., dissenting). The
vaccine mandate still would not be covered by the CSRA
in any event. After all, the peephole camera in Gustafson was in the workplace. See 803 F.3d at 886-87.
So too with the hypothesized wiretaps in Bush. See 462
U.S. at 385 n.28. So too with the assaults in Brock.
See 64 F.3d at 1425. The reason these illegalities were
actionable outside of the CSRA had nothing to do with
the location or timing of the employer’s actions. They
were actionable outside of the CSRA because the definition of “personnel action” cannot reasonably be read to
include peephole cameras, assaults, or illegal wiretaps.
The same is true of irrevocable medical decisions. The
fact that the President ordered employees to make
medical decisions outside of the workplace—and to live
with those irrevocable decisions even after they leave
the federal workforce—bolsters plaintiffs’ argument
that the mandate is not a “working condition.” But it’s
not necessary.
D.
The dissenting opinion next contends that its reading
of the CSRA is compelled by “the logic of Fausto.”
Post, at 64 (Higginson, J., dissenting). Again, we respectfully disagree.
Fausto involved the removal of a federal employee—
unquestionably a “personnel action” covered by the
CSRA. See 5 U.S.C. §§ 2302(a)(2)(A)(iii), 7512(1) (covering “a removal”). While the CSRA covered the employer’s personnel action, it did not cover Fausto himself
because he served in the “excepted service.” Fausto,
484 U.S. at 441 & n.1.
Because Congress carved
35a
Fausto out of the CSRA’s coverage, he sought remedies
under a different federal statute called the Back Pay
Act, 5 U.S.C. § 5596. The question presented was
whether Congress’s decision not to cover Fausto under
the CSRA impliedly preempted his ability to seek more
generous remedies under the Back Pay Act.
The
Court held yes because to hold otherwise “would have
given him greater rights than were available under the
CSRA to employees who enjoyed rights under that
statute—primarily those in the competitive service.”
Graham, 358 F.3d at 934.
Likewise in Graham, the D.C. Circuit held that an
employee covered by the CSRA must use that process—
and only that process—to challenge his employer’s personnel actions. See ibid. And it did not matter that
the particular personnel action at issue in Graham (the
issuance of a censure letter) was not one of the listed
personnel actions covered by the CSRA. As thenJudge Roberts wrote: “in granting review with respect to some personnel actions under the CSRA, Congress meant to preclude review of others.” Ibid.
These cases teach that the CSRA establishes a comprehensive framework for (1) federal employees challenging (2) personnel actions. Under both Fausto and
Graham, an employee cannot avoid the CSRA’s implicit
stripping of § 1331 jurisdiction by saying “Congress’s
decision to limit (1) covered employees and (2) covered
personnel actions” should be read to allow (1) uncovered
employees to avoid the CSRA or (2) judicial review of
uncovered personnel actions.
But neither decision strips § 1331 jurisdiction over
claims that do not challenge personnel actions. That’s
why, again, the Supreme Court said that federal em-
36a
ployees can bring claims unrelated to personnel actions
outside of the CSRA. See Bush, 462 U.S. at 385 n.28.
Congress certainly could pass a statute that says, “federal employers are suable under the CSRA and only under the CSRA.” But that’s not what Congress said.
Congress said personnel-action claims must go through
the CSRA process—thus leaving undisturbed whatever
§ 1331 jurisdiction might otherwise attach to claims unrelated to personnel actions, like wiretaps, peephole
cameras, and irrevocable medical decisions.
E.
The dissenting opinion is also incorrect to contend
“this case is justiciable because it involves challenges to
CSRA-covered personnel actions.” Post, at 67 (Higginson, J., dissenting). The dissent’s theory appears to
be that plaintiffs only have standing because the Government threatens to take CSRA-covered personnel actions against noncompliant employees. See ibid.
We respectfully disagree because the plaintiffs alleged an injury distinct from any personnel action.
The mandated medical decision alone is an injury.
When a “regulation is directed at [plaintiffs] in particular” and “requires them to make significant changes,”
plaintiffs have suffered an injury to challenge the order
even if the Government has yet to elucidate the precise
consequences of failing to comply. Abbott Lab’ys v.
Gardner, 387 U.S. 136, 154 (1967); see also Lujan v.
Defs. of Wildlife, 504 U.S. 555, 561-62 (1992). Plaintiffs
do not have to identify exactly how the Government will
enforce the mandate; it’s enough that plaintiffs face the
ominous order, “get vaccinated or else.” See Abbott
Lab’ys, 387 U.S. at 151 (holding that plaintiffs subject to
a regulation had standing to challenge it even though the
37a
Attorney General had yet to “authorize criminal and seizure actions for violations of the statute”).
Moreover, plaintiffs did not seek or receive relief
against any personnel action. Plaintiffs only sought an
injunction against the executive order. The executive
order nowhere references any threatened or actual personnel action. See EXEC. ORDER 14043. And the district court’s injunction nowhere restricts the Government from bringing personnel actions against plaintiffs.
Rather, it prevents the Government from “implementing or enforcing Executive Order 14043 until this case is
resolved on the merits.” ROA. 1770. The Government is thus prohibited from ordering plaintiffs to get
vaccinated—but the Government is not prohibited from
taking personnel actions against them.
True, when a plaintiff seeks pre-enforcement review
of a government mandate, ripeness is always a concern.
See, e.g., Abbott Lab’ys, 387 U.S. at 148. But in this
case, it’s not difficult “to evaluate both the fitness of the
issues for judicial decision and the hardship to the parties of withholding court consideration.” Id. at 149.
The issue for judicial decision is the purely legal one of
whether the President can lawfully enact this order.
See ibid. (holding “the issues presented are appropriate
for judicial resolution at this time” because “all parties
agree that the issue tendered is a purely legal one”).
And the hardships to the plaintiffs of withholding a decision are plain: they’ll be forced to undergo irrevocable medical procedures and comply with a potentially
unlawful order or face unknown consequences that “may
be even more costly.” See id. at 153; id. at 152 (finding
hardship and hence ripeness where “[t]he regulations
are clear-cut, and were made effective immediately upon
38a
publication; [and the Government’s lawyers made clear]
that immediate compliance with their terms was expected”). The mandate thus plainly affects plaintiffs’
“primary conduct” and hence is ripe for review irrespective of any personnel actions the Government has taken
or might eventually take. Nat’l Park Hosp. Ass’n v.
Dep’t of Interior, 538 U.S. 803, 810 (2003).
F.
Finally, the dissenting opinion claims that “[t]his circuit’s door is now open to all pre-enforcement challenges
to federal employment policies. Plaintiffs are welcome
to challenge any personnel action before it takes place.”
Post, at 67-68 (Higginson, J., dissenting) (footnote omitted). “But this is one of those instances in which the
dissent clearly tells us what the law is not.” Waste
Mgmt. of La., L.L.C. v. River Birch, Inc., 920 F.3d 958,
978 (5th Cir. 2019) (Oldham, J., dissenting) (quotation
omitted).
Plaintiffs in this circuit, as in every circuit of which
we’re aware, are not free to challenge federal personnel
actions under § 1331. Instead, challenges to federal
personnel actions must be channeled through the CSRA
process.
True, § 1331 jurisdiction remains undisturbed for claims that do not challenge federal personnel actions. But even then, the eye of the federal employee’s needle is narrow. The plaintiff still must
demonstrate an injury in fact under well-established
standing principles. And if the employee seeks preenforcement review of a federal mandate, he must sat-
39a
isfy well-established ripeness rules. 8 And even if the
plaintiff can thread that needle, again, he cannot “challenge any personnel action before it takes place.” Post,
at 68 (Higginson, J., dissenting). He can only challenge the Government’s illegal actions that do not constitute a personnel action.
Ours is hardly the first court to recognize that this
needle, while narrow, can be threaded. The plaintiffs
in Gustafson, Brock, Orsay, and Collins all managed to
do it. The sky did not fall, and the doors of the inferior
federal courts were not blown open to claims that otherwise belonged in the CSRA/MSPB process. Therefore
in our view, the dissenting opinion’s rhetoric is misplaced.
VI.
As noted, the panel limited its decision to jurisdiction.
See Feds for Medical Freedom, 30 F.4th at 511. Finding that we have jurisdiction, we review the district
court’s decision regarding the other factors necessary
for a preliminary injunction for abuse of discretion.
See NetChoice, L.L.C. v. Paxton, 49 F.4th 439, 447 (5th
Cir. 2022). “A preliminary injunction is an extraordinary remedy never awarded as of right.” Winter v.
Nat. Res. Def. Council, Inc., 555 U.S. 7, 24 (2008). “A
plaintiff seeking a preliminary injunction must establish
that he is likely to succeed on the merits, that he is likely
to suffer irreparable harm in the absence of preliminary
relief, that the balance of equities tips in his favor, and
that an injunction is in the public interest.” Id. at 20.
For example, the district judge in this case rejected a previous
challenge to this same mandate as unripe. See Rodden v. Fauci,
571 F. Supp. 3d 686, 689 (S.D. Tex. 2021).
8
40a
The district court carefully considered these factors and
wrote a thorough opinion explaining its decision to grant
preliminary relief. After carefully considering the district court’s opinion and the Government’s criticisms of
it, we are unpersuaded that the district court abused its
discretion. And we need not repeat the district court’s
reasoning, with which we substantially agree.
The one issue that warrants additional discussion is
the scope of injunctive relief. The Supreme Court has
recently stayed nationwide injunctions. See, e.g., DHS
v. New York, 140 S. Ct. 599 (2020) (mem.). But the
Court has yet to tell us they’re verboten. Some Justices have expressed concerns that such injunctions can
contravene equitable principles because “[e]quitable
remedies, like remedies in general, are meant to redress
the injuries sustained by a particular plaintiff in a particular lawsuit.” New York, 140 S. Ct. at 600 (Gorsuch,
J., concurring); see also Trump v. Hawaii, 138 S. Ct.
2392, 2426 (2018) (Thomas, J., concurring) (“Universal
injunctions do not seem to comply with those [equitable]
principles.”). For example, the English system of equity did not authorize injunctions against the King.
See Trump, 138 S. Ct. at 2427 (Thomas, J., concurring).
And “as a general rule, American courts of equity did
not provide relief beyond the parties to the case.” Ibid.
As with all general rules, of course, this one was subject
to exceptions—the most important of which was that an
injunction could benefit non-parties as long as “that
benefit was merely incidental.” Ibid.
It appears that the district court did its best to follow
these equitable principles in this case. The court carefully carved the President out of its injunction, which is
an obviously imperfect analogue to the English king but
41a
an equally obvious good-faith recognition of the rule.
It also recognized that, unlike the plaintiffs in both New
York and Hawaii, the lead plaintiff in this case has over
6,000 members spread across every State in the Nation
and nearly every federal agency in the entire Government. ROA. 1770. And plaintiffs cited multiple instances in the aftermath of Executive Order 14043
where the Government wrongfully targeted unvaccinated federal employees who sought exemptions—
despite assurances from the Government that it would
not do so. ROA. 1454, 1464, 1600, 1625, 1645. The
court therefore expressed its “fears that limiting the relief to only those before it would prove unwieldy and
would only cause more confusion.” ROA. 1770. On
this record and absent binding precedent from the Supreme Court, we cannot say that the district court
abused its discretion in rejecting the Government’s assurances that it could and would comply with an injunction limited to the plaintiffs’ members.
The Government’s position on the scope of the injunction also sits awkwardly with its position on the merits.
On the merits, the Government wants “consistency
across government in enforcement of this governmentwide vaccine policy.” ROA. 810. But on the scope of
the injunction, the Government wants piecemeal enforcement, where thousands of plaintiffs’ members
across the Nation are subject to the district court’s injunction, others are given exemptions from vaccination,
and only the remainder are subject to the President’s
mandate. That undermines rather than supports the
Government’s purported interest in “consistency across
government in enforcement of this government-wide
vaccine policy.” ROA. 810.
42a
Finally, a word about concerns expressed by JUDGE
HAYNES and JUDGE STEWART regarding a purported
conflict between this injunction and the decisions of
other courts across the country. They worry that the
district court’s injunction awards relief to parties who
have already lost their claims elsewhere. But our esteemed colleagues reference no cases where plaintiffs
have lost their claims on the merits. They first cite
Rydie v. Biden, No. 21-2359, 2022 WL 1153249 (4th Cir.
Apr. 19, 2022) (unpublished). There, our sister circuit
vacated a district court judgment denying a preliminary
injunction of Executive Order 14043 but only because
the court concluded that the CSRA stripped the district
court of jurisdiction. See id. at *1. The panel dismissed the case under FED. R. CIV. P. 12(b)(1) without
prejudice and without reaching the merits. See id. at
*8 (“We therefore vacate the district court’s judgment
and remand the case with instructions that it be dismissed without prejudice for lack of subject-matter jurisdiction.”). The D.C. Circuit took the same route in
Payne v. Biden, 62 F.4th 598 (D.C. Cir. 2023). See id.
at 607 (dismissing for lack of subject matter jurisdiction
without reaching the merits). In all the other cases
JUDGE STEWART cites, the districts courts dismissed the
claims without prejudice on the grounds that the CSRA
stripped jurisdiction. See Am. Fed’n of Gov’t Emps.
Loc. 2018 v. Biden, 598 F. Supp. 3d 241, 248-49 (E.D. Pa.
2022); Payne v. Biden, 602 F. Supp. 3d 147, 151 (D.D.C.
2022); Am. Fed’n of Gov’t Emps. Loc. 2586 v. Biden, No.
CIV-21-1130-SLP, 2022 WL 3695297, at *6 (W.D. Okla.
July 22, 2022). The overwhelming majority of district
courts that have dismissed these challenges have also
done so for lack of jurisdiction under FED. R. CIV. P.
12(b)(1). See, e.g., Calderwood v. United States, No.
43a
2:21-CV-702-CLM, 2022 WL 4353382 (N.D. Ala. Aug. 25,
2022); Church v. Biden, No. 21-2815 (CKK), 2022 WL
1491100 (D.D.C. May 11, 2022); Am. Fed’n of Gov’t
Emps. Loc. 501 v. Biden, 576 F. Supp. 3d 1155 (S.D. Fla.
2021); McCray v. Biden, 574 F. Supp. 3d 1 (D.D.C. 2021);
Brass v. Biden, No. 21-CV-02778-CNS-MEH, 2022 WL
11732833 (D. Colo. Oct. 20, 2022). Thirteen members
of this court, including JUDGE HAYNES , agree that we
have jurisdiction and must reach the merits of the preliminary injunction. Accordingly, any perceived conflict is misconstrued, and any benefit to outside parties
is “merely incidental.” See Trump, 138 S. Ct. at 2427
(Thomas, J., concurring).
We hasten to emphasize that this case only involves
a preliminary injunction. The preliminary injunction’s purpose is to maintain the status quo until the parties have the chance to adjudicate the merits. See
Benisek v. Lamone, 138 S. Ct. 1942, 1945 (2018) (“[T]he
purpose of a preliminary injunction is merely to preserve the relative positions of the parties until a trial on
the merits can be held. . . . ” (quotation omitted));
Texas v. United States, 809 F.3d 134, 187 n.205 (5th Cir.
2015), affirmed by an equally divided Court, 579 U.S.
547 (2016) (per curiam) (similar). When the parties
proceed to the merits in the district court, the plaintiffs
will have to prove that whatever injunction they request
is broad enough to protect against their proven injuries
and no broader. And the Government will have another chance to show that any permanent injunction
should be narrower than the preliminary one. And
both sides will have to grapple with the White House’s
announcement that the COVID emergency will finally
end on May 11, 2023. See Exec. Off. of the President,
44a
Statement of Administration Policy Re:
H.J. Res. 7 (Jan. 30, 2023).
AFFIRMED.
H.R. 382 &
45a
JAMES C. HO, Circuit Judge, joined by JONES, Circuit
Judge, concurring:
Our court today holds that we have jurisdiction to
hear this challenge to the President’s vaccine mandate
for federal employees. Moreover, by affirming the
preliminary injunction, we also hold that coercing an
employee to comply with a vaccine mandate as a condition of continued employment constitutes irreparable injury.1 I concur.
Judge Higginson agrees that we have jurisdiction.
But he concludes that we should deny relief on the merits and therefore reverse. He notes that “the ‘executive Power’—all of it—is ‘vested in a President,’ who
must ‘take Care that the Laws be faithfully executed.’ ”
Post, at 77 (Higginson, J., concurring in part and dissenting in part) (quoting Seila Law LLC v. Consumer
Fin. Prot. Bureau, 140 S. Ct. 2183, 2191 (2020) (quoting
U.S. CONST. art. II, § 1, cl. 1; id. at § 3)). He concludes
that the President possesses the constitutional authority to order federal employees to comply with his vaccine
mandate, if they wish to avoid removal from office.
I certainly agree that “[t]he entire ‘executive Power’
belongs to the President alone.” Seila Law, 140 S. Ct.
at 2197. Contrast U.S. CONST. art. I, § 1 (vesting the
legislative power in a bicameral Congress); id. art. III,
Cf. NFIB v. OSHA, 142 S. Ct. 661, 665 (2022) (“A vaccination
. . . cannot be undone at the end of the workday.”) (quotations
omitted); Louisiana v. Biden, 55 F.4th 1017, 1022 (5th Cir. 2022)
(noting that “employees would have to undertake an irreversible
decision—vaccination—in order to be compliant with this mandate”); see also Sambrano v. United Airlines, Inc., 45 F.4th 877,
878-79 (5th Cir. 2022) (Ho, J., concurring in denial of rehearing en
banc) (same).
1
46a
§ 1 (vesting the judicial power in “one supreme Court,
and in such inferior Courts as the Congress may from
time to time ordain and establish”). To be sure, “it
would be impossible for one man to perform all the great
business of the State.” Seila Law, 140 S. Ct. at 2197
(quotations omitted). So “the Constitution assumes
that lesser executive officers will assist the supreme
Magistrate in discharging the duties of his trust.” Id.
(quotations omitted). But “[t]hese lesser executive officers must remain accountable to the President, whose
authority they wield.” Id.
All of this means that the President should possess
the constitutional authority under Article II to remove
his subordinates from office. See, e.g., Myers v. United
States, 272 U.S. 52, 122, (1926) (“[W]hen the grant of the
executive power is enforced by the express mandate to
take care that the laws be faithfully executed, it emphasizes the necessity for including within the executive
power as conferred the exclusive power of removal.”);
Free Enter. Fund v. Pub. Co. Acct. Oversight Bd., 561
U.S. 477, 498 (2010) (insulating subordinates from
removal “subverts the President’s ability to ensure that
the laws are faithfully executed—as well as the public’s
ability to pass judgment on his efforts”); Seila Law, 140
S. Ct. at 2203-04 (observing that “the threat of removal”
allows the President to “meaningfully control[]” subordinates, and that “removal at will” is “the most direct
method of presidential control”); Collins v. Yellen, 141
S. Ct. 1761, 1787 (2021) (“The President must be able to
remove not just officers who disobey his commands but
also those he finds negligent and inefficient, those who
exercise their discretion in a way that is not intelligent
or wise, those who have different views of policy, those
who come from a competing political party who is dead
47a
set against [the President’s] agenda, and those in whom
he has simply lost confidence.”) (cleaned up). 2
In reality, however, the President actually controls
surprisingly little of the Executive Branch. Only a tiny
percentage of Executive Branch employees are subject
to Presidential removal. The overwhelming majority
of federal employees, by contrast, are protected against
Presidential removal by civil service laws. Compare
OFF. OF MGMT. & BUDGET, EXEC. OFF. OF THE PRESIDENT, BUDGET OF THE UNITED STATES GOVERNMENT,
FISCAL YEAR 2023, at 83 (2022) (4.2 million Executive
Branch employees), with HOUSE COMMITTEE ON OVERSIGHT AND REFORM, UNITED STATES GOVERNMENT
POLICY AND SUPPORTING POSITIONS 209-15 (2020)
(commonly known as the “Plum Book”) (fewer than four
thousand Executive Branch employees are subject to removal at will by the President).
The net result is that there are only a “small number
of politically appointed leaders” who “enjoy only limited
control of the mass of civil servants.” Eric Posner,
And if Elected: What President Trump Could or
Couldn’t Do, N.Y. TIMES, June 3, 2016. Federal civil
service laws make it virtually impossible for a President
to implement his vision without the active consent and
cooperation of an army of unaccountable federal employees. And that presents a rather curious distortion
But see Collins v. Mnuchin, 938 F.3d 553, 614 (5th Cir. 2019)
(en banc) (Higginson, J., dissenting in part) (“The Constitution affords sparse materials to resolve this question—only broad pronouncements that ‘[t]he executive Power shall be vested’ in the
President and that ‘he shall take Care that the Laws be faithfully
executed.’ Art. II §§ 1, 3. These clauses say nothing about removal of executive-branch officers.”).
2
48a
of our constitutional structure. The Constitution requires the President, the Vice President, and every
member of Congress to stand for re-election if they wish
to continue holding federal office and exercising federal
power. Meanwhile, countless Executive Branch employees have the ability to influence or implement
federal policy in their capacity as subordinates of the
President—yet they enjoy a de facto form of life tenure,
akin to that of Article III judges. See U.S. CONST. art.
III, § 1 (“The Judges, both of the supreme and inferior
Courts, shall hold their Offices during good Behaviour”).
It’s a phenomenon that legal scholars have identified
(and decried) for decades. “The critical fact of civil service today is that covered employees are rarely discharged from government for inadequately doing their
jobs. The civil service system has provided the equivalent of life tenure (at least until retirement) once a brief
probation period is passed, absent what the government
considers a serious act of misconduct.” Gerald E.
Frug, Does the Constitution Prevent the Discharge of
Civil Service Employees?, 124 U. PA. L. REV. 942, 945
(1976). See also PHILIP K. HOWARD, NOT ACCOUNTABLE: RETHINKING T HE CONSTITUTIONALITY OF PUBLIC EMPLOYEE UNIONS 136 (2023) (“Federal government . . . is an accountability-free zone. More federal employees die on the job than are terminated for
poor performance. Regular stories emerge of employees who cannot be terminated despite outrageous behavior.”).
Not surprisingly, these “tenure-like protections for
the civil service have sharply reduced the president’s
ability to change the direction of the permanent bureau-
49a
cracy.” John Yoo, Unitary, Executive, or Both?, 76 U.
CHI. L. REV. 1935, 1956 (2009).
What’s more, federal employees know it—and they
take full-throated advantage of it. As anyone who has
ever held a senior position in the Executive Branch can
attest, federal employees often regard themselves, not
as subordinates duty-bound to carry out the President’s
vision whether they personally agree with it or not, but
as a free-standing interest group entitled to make demands on their superiors. See, e.g., Philip K. Howard,
Civil Service Reform: Reassert the President’s Constitutional Authority, THE AMERICAN INTEREST, Jan.
28, 2017 (“The slow dissipation of presidential power is
a story rich with irony—designed to avoid interest
group capture, the civil service became its own special
interest.”).
As a result, “Presidents can have a hard time implementing their agenda if civil servants collectively drag
their feet or lack the competence to carry out the President’s orders.”
Jason Marisam, The President’s
Agency Selection Powers, 65 ADMIN. L. REV. 821, 863
(2013). “Even if a president has the perfect ally running an agency, that ally may still fail to produce the desired results if the ally runs into resistance from his civil
servants.” Id.
Indeed, one scholar has pointedly noted that the single “biggest obstacle” for any President “is not the separation of powers” designed by our Founders, “but the
millions of federal employees who are supposed to work
for him.” Posner, supra (emphasis added). “These
50a
employees can drag their feet, leak to the press,
threaten to resign and employ other tactics to undermine [a President’s] initiatives if they object to them.”
Id. “They’re also hard to fire, thanks to Civil Service
protections.” Id. See, e.g., Marisam, supra, at 863-64
(“For example, the efforts of President Reagan’s EPA
Administrator, Ann Gorsuch, to slow down and halt
EPA regulatory actions was marked by staff resistance
to the Administration’s attempt to change the agency’s
goals.”) (cleaned up).
In an appropriate case, we should consider whether
laws that limit the President’s power to remove Executive Branch employees are consistent with the vesting of
executive power exclusively in the President. See, e.g.,
HOWARD, NOT ACCOUNTABLE , supra, at 140 (“[T]he
president and federal supervisory officials must have
authority to manage personnel. . . . This requires,
among other remedies, invalidating specific provisions
of the Civil Service Reform Act of 1978 that . . . disempower the president and his appointees from removing officers.”); Yoo, supra, at 1957 (“[P]residents consistently followed a common position toward the civil
service that sought to maintain the right to fire federal
employees in order to guarantee a uniform execution of
federal law.”); Christopher S. Yoo, Steven G. Calabresi,
and Anthony J. Colangelo, The Unitary Executive in the
Modern Era, 1945-2004, 90 IOWA L. REV. 601, 660 (2005)
(“[T]he idea that the civil service laws limit the president’s power to remove is of fairly recent vintage dating
back only to 1974.”); Frug, supra, at 949 (noting that
“the President’s absolute power of removal of federal
employees was established in principle” in 1789).
51a
This is not that case, however. That’s because the
Government doesn’t challenge the validity of the CSRA
or invoke the President’s Article II removal power in
this case. It doesn’t do so in its briefing. And it reconfirmed during oral argument that it doesn’t challenge the constitutionality of the CSRA here. During
oral argument, I asked whether the President has the
power under the Constitution to remove any Executive
Branch employee, notwithstanding laws like the CSRA.
Counsel for the Government responded: “Plaintiffs
say periodically we haven’t challenged the constitutionality of the CSRA. That’s absolutely right—we have
not.” Oral Arg. at 5:40-6:23.
The argument is thus forfeited. We therefore have
no occasion to decide whether this case implicates the
President’s constitutional power to remove employees
who are unwilling to faithfully execute his policy vision
for our country—or if, instead, the President is impermissibly leveraging (and therefore exceeding) his removal power in order to meddle in the private lives of
federal employees. See post, at 52 (Higginson, J., concurring in part and dissenting in part) (noting that the
President’s vaccine mandate “requires federal employees to ‘protect themselves’ against COVID-19 by getting
FDA-approved vaccinations”); cf. Louisiana v. Biden,
55 F.4th 1017, 1030 (5th Cir. 2022) (“unlike the non-
52a
discrimination, E-Verify, Beck rights, and sick leave orders, which govern the conduct of employers, the [President’s federal contractor] vaccine mandate purports to
govern the conduct of employees—and more than their
conduct, purports to govern their individual healthcare
decisions”).3
See also Horvath v. City of Leander, 946 F.3d 787, 799 (5th Cir.
2020) (Ho, J., concurring in the judgment and dissenting in part)
(observing that a municipal vaccine mandate “forces [an employee]
to choose between sacrificing his faith or working under unequal
conditions”); BST Holdings, L.L.C. v. Occupational Safety &
Health Admin., 17 F.4th 604, 618-19 (5th Cir. 2021) (OSHA vaccine
mandate implicates “the liberty of individuals to make intensely
personal decisions according to their own onvictions”); Sambrano
v. United Airlines, Inc., 19 F.4th 839, 841 (5th Cir. 2021) (Ho, J.,
dissenting) (“Vaccine mandates . . . present a crisis of conscience for many people of faith. It forces them to choose between
the two most profound obligations they will ever assume—holding
true to their religious commitments and feeding and housing their
children.”); Sambrano v. United Airlines, Inc., 2022 WL 486610,
*9 (5th Cir. Feb. 17, 2022) (“United has presented plaintiffs with
two options: violate their religious convictions or lose all pay and
benefits indefinitely. That is an impossible choice for plaintiffs
who want to remain faithful but must put food on the table.”).
3
53a
HAYNES, Circuit Judge, concurring in the judgment in
part and dissenting in part:
I.
Concurrence
I concur in the en banc court’s judgment that we have
jurisdiction over pre-enforcement challenges to President Biden’s vaccine mandate for federal employees. I
also concur in the affirmance of the preliminary injunction as to the parties in this case, but I respectfully dissent from the affirmance of the grant of a nationwide injunction.
II.
Dissent1
The district court noted that it was “cognizant of the
‘equitable and constitutional questions raised by the rise
of nationwide injunctions.’ ” Feds for Medical Freedom v. Biden, 581 F. Supp. 3d 826, 836 (S.D. Tex. 2022)
(quoting Dep’t of Homeland Sec. v. New York, 140 S. Ct.
599, 601 (2020) (Gorsuch, J., concurring)). Nevertheless, the district court concluded that tailoring relief
here was impractical. 581 F. Supp. 3d at 836. According to the district court, the fact that the lead Plaintiff—
Feds for Medical Freedom—has more than 6000 members spread across every state and in nearly every federal agency means that limiting the injunction’s scope
would “prove unwieldy and would only cause more confusion.” Id. (quotation omitted).
However, a federal court’s “constitutionally prescribed role is to vindicate the individual rights of the
people appearing before it,” and accordingly “[a] plaintiff ’s remedy must be tailored to redress the plaintiff ’s
particular injury.” Gill v. Whitford, 138 S. Ct. 1916,
1
Judges Higginson and Willett join in Section II.
54a
1933-34 (2018) (emphasis added); see also Dep’t of
Homeland Sec., 140 S. Ct. at 600 (Gorsuch, J., concurring) (“[W]hen a court . . . order[s] the government
to take (or not take) some action with respect to those
who are strangers to the suit, it is hard to see how the
court could still be acting in the judicial role of resolving
cases and controversies.”); Georgia v. President of the
United States, 46 F.4th 1283, 1303 (11th Cir. 2022) (“In
their universal reach to plaintiffs and nonplaintiffs alike,
nationwide injunctions push against the boundaries of
judicial power, and very often impede the proper functioning of our federal court system.”). This seems especially true where, as here, several district courts (and
two circuit courts) across the country have come out differently from this district court on these issues.2 For
instance, the Government noted that it has successfully
defended the executive order in the Fourth Circuit3 and is
currently defending the dismissal of similar challenges in
the Third and D.C. Circuits,4 “[b]ut those cases are ren-
At least twelve district courts previously rejected challenges to
Executive Order 14043 for various reasons. See Feds for Med.
Freedom, 30 F.4th at 505 n.1 (collecting cases).
3
The Fourth Circuit, like the panel opinion in this case, determined that the CSRA deprived the district court of jurisdiction.
Accordingly, it vacated the district court’s judgment denying relief
to the plaintiffs on the merits and dismissed the suit for lack of
jurisdiction. Rydie v. Biden, No. 21-2359, 2022 WL 1153249, at *8
(4th Cir. Apr. 19, 2022).
4
The Government subsequently noted that the D.C. Circuit
ruled in its favor. See Payne v. Biden, 62 F.4th 598 (D.C. Cir.
2023).
2
55a
dered essentially meaningless by this nationwide injunction.”5
Nor is tailored injunctive relief unworkable here.
The district court could direct Feds for Medical Freedom to submit the names of its members to the Government and employing agencies in order to provide them
relief. If it has not already done so, Feds for Medical
Freedom also could provide either online proof of membership or physical cards to that effect that the unvaccinated individual member employees could utilize as
proof to avoid any adverse employment actions. Additionally, as the Government notes, “[a]s for the court’s
view that tailored relief would be unworkable because
[Feds for Medical Freedom] ‘is actively adding new
member[s],’ it is far from clear that [Feds for Medical
Freedom] has standing to litigate on behalf ” of potential
or future members. 6 In contrast, the plaintiffs wholly
The majority opinion misunderstands my point here:
we
should generally only address the parties’ request for a preliminary injunction, particularly in this circumstance, where other litigants are raising the same issues in other circuits. In other
words, I am less concerned with whether we are creating circuit
splits than whether we are appropriately limiting the scope of our
decisions to the parties before us. The reasoning other circuits
use to resolve these issues is therefore not my point. That said,
the majority is plainly incorrect that its opinion doesn’t truly conflict with other courts’ decisions. The other circuits’ jurisdictional
rulings are far from “merely incidental”—they are wholly fatal to
the plaintiffs’ claims. Therefore, a nationwide ruling which the
majority opinion seems to find overrules the other circuits is also
problematic because we have no greater jurisdiction to grant relief
(or make decisions about federal court jurisdiction) than the other
circuits.
6
The majority opinion’s last substantive paragraph notes that
this case “only involves a preliminary injunction” which has the
5
56a
failed to meet their burden to show that tailoring was
not workable. See, e.g., Ashcroft v. ACLU, 542 U.S.
656, 666 (2004) (on appeal from grant of preliminary injunction, the party who “bears the burden of proof on
the ultimate question” bears the same burden on appeal); Enter. Int’l, Inc. v. Corporacion Estatal Petrolera
Ecuatoriana, 762 F.2d 464, 472 (5th Cir. 1982) (“[T]he
district court must remember that a preliminary injunction is an extraordinary and drastic remedy, and that
the movant has a heavy burden of persuading the district court that all four elements are satisfied. Thus, if
the movant does not succeed in carrying its burden on
any one of the four prerequisites, a preliminary injunction may not issue and, if issued, will be vacated on appeal.” (internal quotation marks, alteration, and citation omitted) (emphasis added)).
III.
Conclusion
Accordingly, the district court erred in issuing a nationwide injunction when a tailored injunction is not unworkable or impossible to apply. Therefore, I dissent
from the court’s decision to leave the nationwide injunction in place rather than reversing the portion of the injunction that extends beyond the plaintiffs.
“purpose to maintain the status quo until the parties have the
chance to adjudicate the merits.” Ante, at 37 (emphasis added).
Exactly—we should not address the interests of non-parties where,
as here, it is certainly feasible to tailor the injunctive relief to the
plaintiffs.
57a
STEPHEN A. HIGGINSON, Circuit Judge, joined by
SOUTHWICK, Circuit Judge, concurring in part and dissenting in part:
This case begins with the question of whether we
have jurisdiction to review the President’s vaccine requirement for Executive Branch employees. If the answer is yes, we also must decide whether the President’s
order exceeded his authority to require his employees to
get an FDA-approved vaccination during a pandemic
that has killed over a million Americans.
For the wrong reasons, our court correctly concludes
that we do have jurisdiction. But contrary to a dozen
federal courts—and having left a government motion to
stay the district court’s injunction pending for more
than a year—our court still refuses to say why the President does not have the power to regulate workplace
safety for his employees.
* * *
The Civil Service Reform Act of 1978 (CSRA), 5
U.S.C. § 1101 et seq., generally precludes subject-matter
jurisdiction over pre-enforcement challenges to Executive Branch employment policies. For that reason, I
cannot agree with our court’s blueprint for covered employees to short circuit the CSRA by filing a federal lawsuit against workplace regulations before they are disciplined. Now, litigants can forum shop challenges to
federal employment policies in our court, even though
Congress directed their cas
This text is long and has been trimmed here. Open the source document for the complete record.
This is a copy of a public record, reproduced as it was published. It is not legal advice, and it may not be the version a court would rely on. Check the official source before you cite it.